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Zusammenfassung
In menschlichen Zellen gibt es mehr als fünfhundert simultan arbeitende Kinasen. Das 
Verständnis ihrer räumlich-zeitlichen Regulation ist nicht nur ein wichtiger Schlüssel zum 
besseren Verständnis der molekularen Mechanismen menschlicher Erkrankungen, sondern 
auch für die Entwicklung neuer Therapien notwendig. In dieser Studie konzentrierte ich 
mich auf die detaillierte Untersuchung der Regulierungsmechanismen der Proteinkinase C 
(PKC)-Familie, einer ubiquitär vorkommenden Kinase-Familie.
PKC!ein Mitglied dieser Familie, reagiert auf Ca2+-Freisetzung und transloziert 
diffusionsbegrenzt an die Plasmamembran. Diese Translokation ist ein Schlüsselereignis in 
der Aktivierung von konventionellen PKCs (cPKCs). Im ersten Abschnitt meiner 
Dissertation habe ich grundlegende Eigenschaften dieser frühen Schritte der Kinase-
Akt iv ie rung un te r such t . Für d iesen Zweck habe i ch mikroskopische 
Fluoreszenzuntersuchungen an lebenden Zellen durchgeführt und die Kinetik der PKC!-
Translokation unter Verwendung von Fusionsproteinen mit unterschiedlichem 
Molekulargewicht gemessen. Translokationen wurden durch die kontrollierte Ca2+-
Freisetzung mittels UV-Blitzlicht-Photolyse eingeleitet, welches eine relative Bestimmung 
der Geschwindigkeit der Ca2+-induzierten PKC!-Translokation erlaubte. Das Ergebnis 
dieser Untersuchungen zeigt, dass die Translokationseigenschaften mit einem 
ausschließlich diffusionsgesteuerten Prozess kompatibel sind. 
Die mögliche Beteiligung des Zytoskeletts an der PKC!-Translokation blieb dennoch eine 
entscheidende Frage zum besseren Verständnis der PKC!-Aktivierung. Zu deren 
Beantwortung untersuchte ich die Translokation der PKC! nach pharmakologischer 
Depolymerisation des Aktins und des Mikrotubuli-Netzwerks. Ich stellte fest, dass keine 
dieser Zytoskelett-Komponenten die Eigenschaften der PKC!-Translokation beeinflusste 
und konnte daraus schlussfolgern, dass das Zytoskelett keinen Beitrag zur Kinetik der 
PKC! Translokation leistet.
Die cPKC-Moleküle funktionieren nicht nur als ein idealer Auslesemechanismus für 
globale Ca2+-Signale, sondern folgen auch räumlich-zeitlich komplexen Ca2+-Signalen mit 
einem ähnlich komplexen Translokationsmuster. Frühere Studien fanden lokale PKC!-
Translokationen in Abhängigkeit von kurzlebigen Ca2+-Freisetzungsereignissen, so 
genannten Ca2+-“Puffs”. Die Lebensdauer dieser Translokationsereignisse überstieg die 
Länge der „Puffs“ um mehr als das 5-fache. Um dieses Verhalten zu verstehen wollte ich 
intermolekulare Wechselwirkungen zwischen membrangebundenen PKC!-Molekülen 
untersuchen. Deren enge Verbindung müsste zu deutlich verlängerten Verweilzeiten an der 
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Membran und zur Bildung von PKC!-Clustern führen. Um dies zu testen, habe ich Förster-
Resonanz-Energie-Transfer (FRET)-Messungen an HEK293-Zellen durchgeführt, die 
gleichzeitig PKC!-GFP und PKC!-eYFP exprimierten. Nach Stimulation der Zellen mit 
dem physiologischen Agonisten ATP konnte ich oszillierende FRET-Signale gleichzeitig 
mit Ca2+-Oszillationen und transienten Membranlokalisationen der PKC! messen. Um die 
alleinige Wirkung von Ca2+ zu bewerten, und die Bindung der PKC an Diacylglycerine 
weitgehend auszuschließen, verwendete ich das Ca2+-Ionophor Ionomycin bei 
verschiedenen extrazellulären Ca2+-Konzentrationen. Für sämtliche Ca2+-Konzentrationen 
wurde ein messbarer Anstieg des FRET-Signals beobachtet. Dies spricht für eine direkte 
Ca2+-Abhängigkeit der PKC!-PKC!-Wechselwirkungen an der Plasmamembran. Darüber 
hinaus zeigten hohe intrazelluläre Ca2+-Konzentration unter diesen Bedingungen einen 
initial starken Anstieg des FRET-Signals, welchem ein spontaner Abfall des Signals folgte. 
Diese Ergebnisse schlossen einen FRET aufgrund einer Kinase-Anreicherung an der 
Plasmamembran als den zugrunde liegende FRET-Mechanismus aus und unterstützen 
ferner das Konzept eines selbstorganisierten PKC!-“Clustering” an der Plasmamembran.
In der ubiquitär exprimierten PKC-Familie teilen sich über 10 PKC-Isoformen ähnliche 
Grundeigenschaften, einschließlich der eher Substrat-unspezifischen Kinase-Domänen, 
Lipid- Bindungsdomänen und auto-inhibitorischen Domänen. Wie sie das spezifische Ziel 
in der Signalkaskade erreichen ist  noch unklar. Doch scheint dieses Wissen für unser 
Verständnis des komplexen Netzwerks von PKC-Signalen in lebenden Zellen essentiell. 
Ich fand, dass gleichzeitig in einer Zelle exprimierte PKC!- und PKC"-Fusionsproteine 
nach physiologischer Stimulation unterschiedliche Muster der Translokation zeigten: 
PKC! translozierte an die Plasmamembran und PKC" wurde an intrazelluläre 
Membranstrukturen rekrutiert, die ich als endoplasmatisches Retikulum (ER) identifizieren 
konnte. Zum besseren Verständnis dieses Verhaltens verfolgte ich verschiedene Ansätze, 
die sowohl chemische Stimulation, als auch molekulare und optische Werkzeuge 
beinhalteten. Meine Ergebnisse zeigten einen bisher unentdeckten G!s-cAMP-EPAC-PLC# 
Signalweg, der für die ER-Rekrutierung der PKC" verantwortlich war. Um die zugrunde 
liegenden Mechanismen besser verstehen zu können, insbesondere welcher Proteinbereich 
für das Translokationsverhalten verantwortlich ist, wurden künstliche PKC-Chimären 
zwischen PKC! und PKC" durch kreuzweisen Austausch ihrer C1-und C2- oder C1A- und 
C1B-Domänen konstruiert. Diese Chimären wurden in HEK293-Zellen zur Expression 
gebracht und ihr Rekrutierungsmuster untersucht. Nach Anwendung einer Vielzahl von 
spezifischen Stimulationen konnte ich die unterschiedliche Rolle dieser Domänstrukturen 
für die Erkennung der Zielmembran zeigen. Außerdem habe ich gezeigt, dass 
ausschließlich die PKC"-C1B-Domäne für die ER-Rekrutierung verantwortlich und auch 
hinreichend ist. Die ER-Lokalisierung der PKC" bewirkt eine lokale Phosphorylierung, die 
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durch gezielte Phosphorylierungssensoren und die physiologische Verkürzung der ATP-
induzierten Ca2+-Oszillationen durch Kinase-vermittelte InsP3-Rezeptor-Phosphorylierung 
gezeigt wurde. Schlussfolgernd zeigen meine Ergebnisse, dass die vielseitige Kombination 
eines autonomen C-Domäne-Signalbaukastens die einzigartigen Funktionen der PKCs 
ermöglicht. Dies beinhaltet die gleichzeitige Entschlüsselung von Lipid- und Ca2+-Signalen 
auf der speziellen Zielmembran zur Phosphorylierung spezifischer Zielstrukturen.
Zusammenfassend zeigt die Familie der PKCs ihre Fähigkeit in der Raum-Zeit-
Entschlüsselung und der intrazellulären Signalübertragung. Dies führt zu einem neuen und 
elementaren Verständnis und gewährt Einblicke in das Leben von Zellen.
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Abstract
In human cells there are more than five hundred kinases working simultaneously. To 
understand the spatiotemporal regulation of their activity is the key not only  to decode the 
pathology of human diseases but also for the development of new therapies. In this study, I 
focused on the protein kinase C (PKC), a ubiquitous expression kinase family, for detailed 
investigation of their regulatory mechanisms.
As one member of the PKC family, PKC! responses to Ca2+ mobilization and translocates 
to the plasma membrane in a diffusion-limited manner. This translocation is a key event in 
the activation process of conventional PKCs. In the first part of my thesis I investigated 
fundamental properties of this early  step in the kinase activation. For this purpose I 
employed fluorescent imaging techniques of living cells to investigate the kinetics of 
PKC! translocation utilizing fusion constructs with different molecular weight. 
Translocation was initiated by UV flash photolysis of caged Ca2+ that allowed the 
determination of the relative speed of Ca2+-induced PKC! translocation. The result of these 
studies show that the translocation properties are compatible with solely diffusion-driven 
process. Nevertheless, whether the cytoskeleton contributes to PKC! translocation 
remained a critical question for understanding PKC! activation. By pharmacologically 
depolymerizing the actin and microtubule network I investigated translocation properties 
of PKC! and found that none of these cytoskeleton components affected PKC! 
translocation and thus I concluded that the cytoskeleton was not contributing to the kinetics 
of PKC! translocation. 
The cPKC molecules not only  work as an ideal read-out  mechanism for global Ca2+ signal, 
but also follow spatiotemporally complex Ca2+ signals with similar complex translocation 
regimes. Previous studies found local translocation events of PKC! resulting from short-
lived Ca2+ release events, so called Ca2+ puffs, whose lifetime exceeded the puffs’ lifetime 
by more than 5 fold. To explain this behavior, we proposed intermolecular interactions 
between membrane-bound PKC! molecules that  must be so tight that they significantly 
prolong membrane residence times of these PKC! molecules and form PKC! clusters. To 
test this, I used Förster resonance energy transfer (FRET) measurements in PKC!-CFP and 
PKC!-eYFP co-expressed HEK293 cells and stimulated the cells with the physiological 
agonist ATP. Oscillatory FRET signals were observed concomitantly with Ca2+ oscillations 
and transient membrane translocations of PKC!. To evaluate the sole effect of Ca2+ and 
largely exclude DAG binding of the PKC, I employed the Ca2+ ionophore ionomycin in 
various extracellular Ca2+ concentrations. At all Ca2+ concentrations a measurable FRET 
increase was observed strongly indicating a direct Ca2+-dependent PKC!-PKC! interaction 
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on the plasma membrane. Moreover, high intracellular Ca2+ concentrations additionally 
evoked a spontaneous decay  of FRET signal following the strong upstroke of the FRET 
under these circumstances. These results excluded molecular crowding of the kinase on the 
plasma membrane as the underlying FRET-generating mechanism and further supported a 
self-organized PKC! clustering on the plasma membrane.
In the ubiquitously expressed PKC family, over 10 isoforms of PKCs share similar basic 
construct features, including the rather substrate-unspecific kinase domain, lipid binding 
domains and autoinhibitory  domains. How they achieve the specific target during in signal 
cascade is still unclear but appears essential for our understanding of the complex network 
of PKC signaling in living cells. I found that when co-expressing fluorescent protein fusion 
proteins of PKC! and PKC" in the same cell treated with physiological stimulation, the 
PKCs display different patterns of translocation: PKC! translocated to the plasma 
membrane and PKC" was recruited to intracellular membrane structures that I identified as 
the endoplasmic reticulum (ER). To foster understanding of this behavior, I employed 
several different approaches including chemical compounds, molecular and optical tools. 
My result demonstrated a novel G!s-cAMP-EPAC-PLC# signal pathway that was 
responsible for the PKC" ER targeting. To further understand the underlying mechanism 
and in particular which part of the molecules was responsible for what translocation 
behavior, artificial PKC chimeras between PKC! and PKC" were constructed by 
exchanging their C1 and C2 or C1A and C1B domains crosswise, expressing them in 
HEK293 cells and investigating their recruitment patterns. Following application of a 
variety of specific stimuli, I could reveal the independent role of these domain structures 
for target membrane recognition. Furthermore I demonstrated that  it was PKC"’s C1B-
domain that solely  and sufficiently determined ER recruitment. The ER targeting of PKC" 
caused a local phosphorylation as probed by targeted phosphorylation sensors and 
physiologically shortening of ATP-induced Ca2+ oscillations via kinase-mediated InsP3 
receptor phosphorylation. In conclusion, my results demonstrate that the versatile 
combination of an autonomous C-domain signaling toolkit  enables the unique functions of 
PKCs as coincidence detectors decoding lipid and Ca2+ signaling into phosphorylation on 
the specific targeted membrane.
Taken together, PKCs as one family  of protein kinases display their abilities in 
spatiotemporal decoding and transduction intracellular signaling, which provide novel and 
elementary understanding and insights into the life of cells.
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Chapter 1 
INTRODUCTION
Protein kinases are catalytic enzymes that have the capability  to modify other proteins by 
chemically  adding a phosphate group to their serine/threonine (Ser/Thr) or tyrosine (Tyr) 
residues. The human genome contains more than 500 genes for protein kinases and 
constitute about 2% of all human genes [1]. Most of the human proteins can be modified 
by kinase activity, and protein kinases are known to mediate most of the signal 
transduction in eukaryotic cells. Protein kinases control many cellular processes by 
modification of substrate activity, including metabolism, transcription, cell cycle 
progression, cytoskeletal rearrangement and cell movement, apoptosis, and differentiation 
[2]. Protein phosphorylation also plays a critical role in intercellular communication during 
development, in physiological responses, in homeostasis, and in the functioning of the 
nervous and immune systems. As such, dysregulation and mutations of protein kinases 
play  causal roles in human diseases, thus offering the possibility  of developing agonists 
and antagonists of these enzymes for use in disease therapy [3-7]. Therefore fully 
understanding the regulation of human protein kinases will aid in deciphering human 
diseases and in the development of therapeutics. In my thesis, I focused on one family of 
protein kinase, the protein kinase C (PKC).
1.1 Protein kinase C family
The first member of the PKC family  was discovered by Nishizuka and co-works in 1977 
[8] and described as the receptors for the potent  tumor promoter the phorbol esters and 
mediators of signaling by  the lipid second messenger diacylglycerol (DAG). Since then 
more than 54,000 research articles have been published, which makes PKCs one of the 
most studied enzyme family. PKCs are ubiquitously  expressed and contribute/regulate a 
remarkable range of signaling pathways, including, but  not limited to, gene expression, cell 
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polarity, cell migration, proliferation and differentiation, T cell recognition, neuronal 
signaling, and metabolism [9-14].
Fig. 1.1.1 Protein kinase C (PKC) family members are located on a branch of the AGC kinome (reproduced 
from www.cellsignal.com/reference/kinase). PKC isoforms enlarged at the position of the AGC kinases on 
the right. Modified from Am J Physiol Endocrinol Metab 298: E395–E402 [15]
The PKC family  is belonging to the serine/threonine protein kinase family, classified to the 
AGC kinase superfamily [16], which account for 60 of the 518 human protein kinases [1]. 
In mammals, 10 isoforms of PKC have been identified so far, which occupy  the tip of a 
branch of the AGC kinases from which the related kinases protein kinase N (PKN), Akt/
PKB, p70 S6 kinase, protein kinase G (PKG), and protein kinase A (PKA) diverge (Fig. 
1.1.1) [1, 15]. These 10 members are highly conserved throughout eukaryotic evolution, 
evolved from a single PKC, PKC1, in saccharomyces cerivisiae [17, 18], and are grouped 
into three classes based on their related domain structure: the conventional or classical 
PKCs (cPKC), novel PKCs (nPKC), and atypical PKCs (aPKC) [15, 19-21]. When 
investigating the phylogenetic tree (Fig. 1.1.1), at the very tip of as mentioned branch there 
are the four conventional PKCs: PKC!, the first cloned enzyme of PKC family; the 
alternatively spliced PKC"I and PKC"II, which differ in the last 43 amino acids, and 
PKC#. cPKCs can be activated by Ca2+ and/or by DAG and phorbol esters. Next in the 
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branch are the four novel PKCs, PKC$, %, &, and ', which are not regulated by Ca2+ but can 
be activated by DAG and phorbol esters. The closest  subfamily  to the branching point are 
the atypical PKCs, PKC( and PKC) (human; murine isoform is PKC*), which are 
unresponsive to Ca2+, DAG and phorbol esters. All PKC isoforms are reported to require 
phosphatidylserine (PS) for optimal activity (Fig. 1.2.1) [22].
1.2 Domain structure of PKCs
In general, all PKC isoforms share basic structural features, such as an N-terminal 
regulatory domain coupling to a highly conserved C-terminal kinase domain with a C-
terminal tail (Fig. 1.2.1). The structure of the N-terminal regulatory domain determines the 
classification of the 10 isoforms of PKCs and plays an essential role in kinase regulation 
and activity. 
Fig. 1.2.1 Domain structures of Protein kinase C (PKC) family members. Shown are the conventional,  novel 
and atypical PKC subfamilies and their corresponding domains in the regulatory domain and C-terminal 
domain. Psd: pseudosubstrate site. Modified from Cellular Signalling 23:753–762 [23]. 
In cPKCs, the N-terminal regulatory  domain comprises a C1A and a C1B domain, which 
binds to DAG or phorbol ester respectively, and a C2 domain, which binds to Ca2+, 
phosphatidylserine, or phosphatidylinositol 4,5-bisphosphate (PIP2). Both cPKCs and 
nPKCs share a similar pattern of regulatory  domains, containing C1 and C2 domains, and 
pseudosubstrate peptides, but in different order. In nPKCs the C2 domain is in front of the 
pseudosubstrate and C1 domain. Importantly, the C2 domains of nPKCs lack the critical 
Ca2+-coordinating amino acids causing nPKCs inability  to bind to Ca2+ [24]. These 
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differences in C2 domain structure may underlie the distinct pharmacology  of cPKC and 
nPKC isoforms. Characterized with short regulatory domains, the aPKCs contain an 
atypical C1 domain with only one cysteine-rich motif binding to phosphatidylinositol 
3,4,5-bisphosphate and a protein-protein interaction domain named PB1 (Phox and Bem 1) 
interacting with other proteins [22, 25]. In all PKCs, pseudosubstrate sequences exist  in the 
regulatory domain that under resting conditions occupy the substrate-binding pocket in the 
C-terminus and block their catalytic activity [26-29]. The detailed properties of each 
domain are described below.
1.2.1 The pseudosubstrate
The pseudosubstrate, present in all PKC isoforms, was originally identified in the 
regulatory region of cPKC by  a stretch of amino acids that were competitive inhibitors of 
PKCs [30, 31]. Further evidence revealed that this sequence served an auto inhibitory role 
in PKC’s activation [27]. By biochemical approaches, it was established that activation of 
cPKC is accompanied by the release of the pseudosubstrate sequence from the kinase 
activity pore [32]. Recently the crystal structure of intact PKC"II eventually  confirmed the 
hypothesis that the pseudosubstrate occupied the substrate-binding cavity of PKCs, thus 
maintaining the enzyme in an inactive conformation [33].
1.2.2 The C1 domain
In PKCs, the C1 domain was identified as a DAG and phorbol ester binding site in PKCs 
with a conserved motif, HX12CX2CXnCX2CX4HX2CX7C, (H stands for histidine, C stands 
for cysteine, X is any other amino acid, and n is 13 or 14 (Fig. 1.2.2). In cPKC and nPKC 
isoforms, this motif occurs as a tandem and forms C1A and C1B domains.
According to the high-resolution crystal structure of the C1B domain from PKC!, PKC"+ 
and I+, PKC#, and PKC$, these C1 domains share similar tertiary  structures and 
functionally anchor the PKCs to membranes by hydrophobic switches [34-36]. Briefly, the 
positive charged C1 domain residues are able to interact with anionic membrane 
phospholipids and penetrate the membrane bilayer to bind DAG, which is located more 
deeply within the membrane leaflet. Lipid cofactors such as phorbol esters then bind to a 
narrow polar groove at the top of the C1 domain [37].
The C1A and C1B domains of PKCs display a broad range of intrinsic affinities, from 1 
nM to more than 3 µM, for lipid cofactors, e.g., DAG and phorbol esters. For instance, the 
C1B domain of PKC! and PKC"II has such a weak DAG binding affinity that under 
physiological conditions it merely contributes to membrane binding. In addition, C1B is 
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more sensitive to PMA than the C1A domain [38, 39]. However, for nPKC isoforms, it was 
variously  reported that the C1B domain of PKC$ and PKC' display a higher affinity for 
both DAG and PMA than their C1A domain. In contrast, the PKC% C1A domain has a 
higher affinity for DAG than its C1B domain [40-44]. Interestingly, there are several 
amino acids which are highly conserved and critical for maintaining the DAG binding 
affinities in both C1A and C1B domains, as shown in Fig. 1.2.2. 
Fig. 1.2.2 Alignment of PKC C1 domains. Numbering is based on PKC!. Conserved cysteine and histidine 
residues are in blue. Other structural determinants of C1 domain function are as indicated on the figure. 
Modified from Physiol Rev 88: 1341–1378 [20].
With respect  to the electrostatic interactions between the C1 domains of PKCs and anionic 
phospholipids of membrane, phosphatidylserine is an important player especially for 
PKC!, PKC"I, and "II [42, 43, 45, 46]. Studies with PKC! have shown that 
phosphatidylserine plays an essential role to disturb intra molecular interactions, which 
form between C1A-C2 pairs, e.g., Asp55-Arg252, Arg42-Glu282, and Phe72-Phe282 residues 
[47]. PKC isoforms also have the abilities to interact with other lipids such as ceramide 
and arachidonic acid via their C1 domains. As previously  reported, ceramide is not only 
able to recruit PKC! from the cytosol to the plasma membrane, but can also cause 
translocation of PKC$/PKC% from the cytosol to the Golgi or other intracellular membrane 
[11, 48]. Arachidonic acid also mimics the effects of ceramide in recruiting PKC% from the 
cytosol to the Golgi, but displays no effects on PKC$. Interestingly, it  inhibits translocation 
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of PKC# to the plasma membrane [42, 49]. Further studies revealed that ceramide binds to 
the C1B domain of PKC$/PKC%, whereas arachidonic acid inhibits PKC# translocation by 
its C1A domain. 
In contrast, the C1 domain of aPKCs contains a cluster of basic residues 
(HLFQAKRFNRRAYCGQCSERI, shown in Fig. 1.2.2) that appear neither in cPKCs nor 
in cPKCs. It was noted that this part in the C1 domain of PKC* might function as a nuclear 
location sequence (NLS) instead of lipid binding [50]. Although the analysis of primary 
sequences of C1 domains in aPKCs can’t entirely explain their inability to bind phorbol 
esters, it appears obvious that there are crucial elements missing in their sequence, such as 
residues that maintain the structure of ligand binding sites or hydrophobic residues 
involved in membrane insertion.
1.2.3 The C2 domain
C2 domains were initially  identified in the regulatory domain of cPKCs as a Ca2+-
dependent membrane-binding motif of about 130 residues [8]. Afterwards, C2 domains 
were found in many  proteins, where they  participate in membrane trafficking and signal 
transduction. In general, C2 domains share a common tertiary  structure comprised of eight 
anti-parallel "-strands connected by  variable loops, in which the sequences of the core "-
strands portion are more homologous than the loop sequences, which are more divergent 
and dictate functional specificity. 
Detailed crystal structure studies of PKC! suggest that several highly conserved Asp 
residues Asp187, Asp193, Asp246, Asp248, and Asp254, in the Ca2+-binding loops bind to two or 
three calcium ions in a highly cooperative manner [51]. Other amino acids are important 
for membrane association. For example, Asn189 is essential for the PS selectivity  of PKC!, 
Arg249/Arg252 contribute to PKC!’s electrostatic interactions with the anionic membrane 
surface, Trp245/Trp247 are involved in hydrophobic interactions with the membrane, and the 
highly  basic lysine-riched "3- and "4-sheets contribute to PKC!-PIP2 binding at the 
membrane [51-54].
In contrast to cPKCs, the C2 domain of nPKCs, also called as C2-like domain, is deficient 
of those Ca2+-binding residues in the loop sequences and therefore binds membranes in a 
Ca2+-independent manner. Moreover, the C2 domain of PKC$ is also unable to bind lipids. 
This is presumably  compensated by  the high intrinsic affinity  of the PKC$ C1 domain for 
lipid-membrane [41]. 
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1.2.4 The kinase domain
The amino acid sequence of PKC catalytic domains highly aligns with most of the residues 
that are invariant across AGC kinase family members such as PKA and AKT [16, 55, 56]. 
Such sequences cluster at  sites of ATP binding and activation (Fig. 1.2.3). Similar to other 
AGC kinases, the catalytic domain of PKCs consists of an N-terminal small lobe, known 
as N-lobe, a C-terminal large lobe, known as C-lobe, and one sandwiched molecule of ATP, 
which serves as the phosphate donor during phosphorylation. The N-lobe contains "-sheets 
and the glycine-rich ATP-binding loop with a consensus GXGXXG sequence, which is a 
marker for nucleotide binding proteins, and an invariant lysine, which forms the active 
residue to transfer the phosphoryl group. At the C-lobe, !-helices are predominant and 
form an activation loop  for magnesium binding and substrate catalysis. Between these two 
main lobes of the kinase domain, there is a “gatekeeper” residue to control access to a 
preexisting cavity  in the ATP binding pocket [57]. The “gatekeeper” residue is conserved 
as a large hydrophobic amino acid in the human kinome [58]. Most notably, mutations at 
this position are the basis of strategies to engineer artificial kinases that are uniquely 
sensitive to certain unnatural ATP analogs to specially inhibit or activate kinases in cell [6]. 
The activation segment of the kinase locates in the C-lobe, adjacent to the ATP-binding 
site, and contains important catalytic elements such as the DFG (Asp–Phe–Gly) motif. The 
Asp residue in the motif is an invariant catalytic residue and responsible for chelating one 
Mg2+ ion that positions the phosphates for phosphotransfer. The activation segment is 
connected to the N-lobe through the !C helix, and its own phosphorylation leads to 
conformational changes, especially  in the !C helix. These changes coordinate the 
formation of a crucial network of hydrogen bonds between a Glu residue on the !C helix, a 
Lys residue in the N-lobe and the phosphates of the ATP; this network is required for the 
catalytic activity of the enzyme [16, 56].
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Fig. 1.2.3 Alignment of PKC kinase domains. (A) The ATP binding site, invariant lysine, and gatekeeper 
residues of PKCs are highlighted in yellow. (B) The Mg2+ positioning loop is shown in green. The 
phosphorylation site of the activation loop,  invariant tyrosine that is phosphorylated in certain PKCs,  is 
depicted in red. Other important residues are indicated in the figure.  Modified from Physiol Rev 88: 1341–
1378 [20].
8
1.2.5 The V5 domain
Following further studies on the PKC family, V5 domains recently  attract increasing 
interests. In general, V5 domains contain 50 to 70 amino acids following the C-terminus of 
the catalytic core of the kinase domain, which mainly  consists of the highly  conserved turn 
motifs (TM) and hydrophobic motifs (HM) as well as an additional 7–21 residues at the 
extreme C-terminus that are highly divergent both in their length and sequence (Fig. 1.2.1). 
Due to such a property, the extreme C-terminal regions of the V5 domain have been 
implemented as epitopes to raise the specificity of antibodies for different PKC isoforms in 
Western blot and immunolabeling studies. 
The C-terminal V5 domain is the only  difference between the two spliced PKC" isoforms, 
PKC"I and PKC"+I. Although PKC"I and PKC"+I are expressed in a tissue-specific and 
developmentally regulated manner [59], they display  distinct translocation patterns upon 
stimulation of metabotropic glutamate receptor-1a (mGluR1a), which couple to the 
hydrolysis of phosphoinositides via G!q proteins. Furthermore, two specific residues, 
Asn625 and Lys668, in the V5 domain of PKC"II are required for the PKC"II-like 
translocation pattern. This can be switched to PKC"I-like translocation pattern simply by 
mutating one of the two residues [60, 61]. 
The C-terminal V5 domain also works as a cis-regulatory element of the enzyme activity 
of PKCs, containing a hydrophobic motif (HM) and a “turn motif”. The hydrophobic 
motif, consisting of a phosphorylatable Ser flanked by hydrophobic residues, locates at the 
C-terminus of the V5 domain, which is found in most AGC kinases [62, 63]. The HM 
wraps around the N-lobe of the kinase domain to insert two aromatic residues into the 
hydrophobic motif pocket. The phosphorylation of their Ser residue is required for keeping 
the ! helix in the active conformation. Since the phosphorylation site in the HM is absent 
in aPKC (Fig. 1.2.4), the negatively charged Glu residue takes its place, structurally 
mimicking the phosphorylated serine/threonine to perform a similar function. Meanwhile, 
the “turn motif”, consisting of a phosphorylatable serine/threonine residue precedes the 
hydrophobic motif, where it assists the C-terminal tail to find its way around the entire N-
lobe. The phosphorylation of the “turn motif” and the corresponding positively charged 
patch on the N-lobe of the kinase is required for kinase stability  and may also protect the 
hydrophobic motif site from dephosphorylation [64]. In all PKCs, the intramolecular 
interactions between the V5 domain and the N-lobe are essential for full kinase activity.
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Fig. 1.2.4 Alignment of the kinase domain V5. The NFD motif is highlighted in green and the 
phosphorylation sites in TM and HM motif are in red. Other important residues are indicated in the figure. 
Modified from Physiol Rev 88: 1341–1378 [20].
Recently, Leonard et al. reported a novel intramolecular interaction between the C1B 
domain and V5 domain around residues 628-630 of PKC"II, referred to NFD (Asn(N)-
Phe(F)-Asp(D)) motif. As a highly conserved catalytic element in the AGC kinases, the 
NFD motif reportedly involves an ! helix. Here, the Phe629 residue is involved in the active 
site and binds the adenine of ATP in the inhibitor-bound kinase domain of PKC"II. 
Leonard et al. found the NFD motif to form a “clamped” conformation that keeps the 
Phe629 out  of the active site, intimately contacting with both the C1B and catalytic 
domains. This conformation prevents the NFD motif from participating in ATP binding and 
eventually stabilizes the active site of the kinase domain [33].
The V5 domain not only regulates the kinase activity  of PKCs, but also modulates PKC-
DAG binding. An intramolecular interaction between V5 domain residues (Asp649, Asp652, 
and Glu654; Fig. 1.2.4) and C2 domain lysine-rich cluster stabilizes the “closed” 
conformation of PKC! and reduces its sensitivity  to DAG, which can be reversed by  V5 
domain truncation or mutations [41, 65].
In addition, there are six amino acids (611KRKVEPPFKPKVK623, shown in Fig. 1.2.4) in 
the V5 domain of PKC$ that act as a nuclear localization sequence (NLS), which results in 
some nuclear expression of PKC$ [66]. Although many of these basic residues are 
conserved in other cPKCs and nPKCs, their function still needs to be elucidated. 
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1.3 Regulation of PKCs
Considering their ubiquitous expression and vital functions in cells, the activity  of PKCs 
must be under a precise regulation in living cells. From what we know today, the function 
of PKCs is regulated by priming phosphorylation, pseudosubstrate exposure, subcellular 
location and its protein degradation in the intracellular context.
1.3.1 Maturation of PKCs
It is believed that all PKC isoforms are rendered mature only  after a series of ordered, 
tightly coupled and constitutive phosphorylations, by  which the enzyme eventually obtains 
the stability and catalytic competence [67, 68]. The earliest step for PKC’s maturation 
is  the binding of the chaperone HSP90 and the co-chaperone Cdc37 to a conserved 
PXXP motif in the C-terminal tail of PKCs to form a molecular clamp in the kinase 
domain, which is essential for phosphorylation occurring [69]. Perturbation of this 
key regulatory step causes either PKC degradation or dysregulation, which provides 
one mechanism in PKC-related diseases: a mutation at the first Proline of this motif 
in PKC! was identified as a mutation driving glioblastoma [70]. 
Fig. 1.3.1 Classical mechanism of PKCs maturation. Premature PKC is bound to chaperone proteins and 
phosphorylated by PDK1 at A-loop around the plasma membrane. Then the protein is phosphorylated by 
mTORC2 complex subsequently at the C-terminal tail to stabilize its conformation. Modified from Nat. Rev. 
Mol. Cell Biol. 11:9–22. [16]
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Priming phosphorylations of PKC are central steps for PKCs maturation. Among the 
multiple predicted phosphorylation residues in the protein, three key  phosphorylation sites 
on the C-terminus of PKC were identified as essential for the kinase activity by mutational 
analysis and mass spectrometry [71, 72]. These are known as the activation loop (A-loop), 
the turn motif (TM), and the hydrophobic motif (HM) (Fig. 1.2.1). Although all three sites 
are conserved in cPKC and nPKC isoforms, the aPKCs do not  contain an HM residue but 
instead of a negatively charged glutamic acid, which may mimic a constitutive 
phosphorylation (Fig. 1.2.1, Fig.1.2.4).
The activation loop in the kinase domain is the first priming site. Phosphoinositide-
dependent protein kinase 1 (PDK1) phosphorylates the activation loop site of all PKC 
isoforms. Following that, the PKC is able to align and stabilize the two lobes of the kinase 
domain in preparation for catalysis (Fig. 1.3.1) [73-75]. Phosphorylation at the A-loop is 
constitutive for cPKC and nPKC but displays agonist dependence for aPKC. Interestingly, 
the activity of PDK1 towards cPKCs is independent of phosphoinositides [76], to which 
the PH domain of C-terminus of PDK1 binds, but it is controlled by the conformation of 
PKC itself [26]. Newly synthesized PKC is in an “open” conformation in which the 
pseudosubstrate is removed from the substrate-binding cavity, thus unmasking the 
activation loop site to allow phosphorylation by  PDK1 (Fig. 1.3.1). Moreover, the 
replacement of the Thr at the A-loop of cPKC with neutral, non-phosphorylatable residues 
(Ala or Val) can prevent the subsequent phosphorylation on TM  and HM sites [77, 78], 
indicating that phosphorylation of the A-loop is necessary to allow TM  and HM motif 
phosphorylation. Such protein mutations in PKCs are highly  susceptible to degradation 
[79]. Therefore, the PDK1 dependent PKC phosphorylation plays a critical role in 
controlling cellular levels of PKC.
Phosphorylation at the activation loop leads to phosphorylation at the second priming site 
within the V5 domain of the turn motif (Fig. 1.3.1) [64]. Structural analysis shows that 
phosphorylation of the TM anchors the C-terminal tail on the N-lobe of the kinase. 
Especially the phosphorylation of the Thr residue within the TM interacts with a cluster of 
basic residues in a pocket above the ATP-binding loop to stabilize the active conformation 
of the kinase that is then resistant to phosphatase activity [80]. The mammalian target of 
the rapamycin 2 complex (mTORC2) plays an important role in TM phosphorylation of 
some PKCs, such as cPKCs and PKC% [81-83]. So far it is unclear whether mTORC2 
directly  phosphorylates PKC, or whether it controls the phosphorylation of this site 
indirectly, e.g., by  accompanying (chaperoning) or positioning freshly  synthesized PKC for 
processing of phosphorylation, or by activating another upstream kinase for this site. Cells 
lacking mTORC2, however, have reduced expressing levels of PKC isoforms [15, 82], 
which is consistent with the essential role of priming phosphorylation in stabilizing PKCs. 
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Since no changes in phosphorylation levels of TM or expression levels of PKC$/' and 
aPKCs have been reported in mTORC2 negative cells [23], other signaling pathways or 
mechanisms of autophosphorylation may  regulate these isoforms at this site. Interestingly, 
the TM of PKC$ has been reported to be an autophosphorylation site [82].
The mechanism of phosphorylation at  the final priming site, the hydrophobic motif site 
(Fig. 1.3.1), seems to be isoform-specific. Kinetic analyses on purified proteins revealed 
that cPKC can be autophosphorylated at the hydrophobic motif by  an intramolecular 
reaction, but this is difficult to resolve in living cells [84]. This site can also be 
phosphorylated in vitro by other kinases, including mTORC2 [82]. For nPKCs, 
interestingly, the phosphorylation of HM  is sensitive to the mTOR inhibitor rapamycin 
[85], which indicates the possible involvement of the mTORC1 complex in the 
phosphorylation of these isoforms. Therefore it appears obviously that mTORC1, 
mTORC2, and other possible pathways have an impact on the HM phosphorylation of 
PKC isoforms and further regulate their function in diverse ways.
Our knowledge of these priming phosphorylations has been derived in large from studies 
of their function in cPKCs. Initial investigations assumed that other PKCs probably follow 
a similar pathway or mechanism to regulate all isoforms. Recent findings, however, have 
demonstrated that this is not always the case. Notable differences were reported for other 
PKC isoforms in terms of the signal transduction influencing the phosphorylation sites and 
the impact they have on isoform-specific function [15, 16, 23].
Table 1.1 Summary  of phosphorylation of A-loop, TM and HM effects on catalytic activity 
of PKC isoforms. Modified from Cellular Signalling 23:753–762 [23].
PKC isoforms A-loop Turn motif Hydrophobic motif
PKC! Required for activity Not required for activity No convinced report
PKC"# Not reported Required for activity Not reported
PKC"## Required for activity Required for activity Not required for activity
PKC$ Not reported Not reported Not reported
PKC% Not reported No convinced report Negative regulation of activity
PKC& Not reported Not required for activity Not reported
PKC' Required for activity Not reported Required for activity
PKC( Not reported Required for activity Not reported
PKC) Required for activity Not required for activity Not exist
PKC* Required for activity Not reported Not exist
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1.3.2 Activation and translocation of PKC
The fully phosphorylated “mature” PKC localizes to the cytosol with the pseudosubstrate 
occupying the substrate-binding cavity and thus silencing the kinase activity. The 
dissociation of the pseudosubstrate from the catalytic cavity is the main step for PKC 
activation. Based on the specific structure of the regulatory domain of the particular PKC 
isoform, the detailed activation mechanism for each isoform is distinctive [20, 22].
Fig. 1.3.2 Activation model of conventional PKC. (1) Upon Ca2+ release, cPKC isoforms translocate to the 
membrane, where Ca2+ bound C2 domain mediate bridging to the anionic phospholipids with an adjoining 
site on the C2 domain-binding PIP2. (2) Subsequent binding of DAG to the C1A domain results in the 
removal of the pseudosubstrate from the catalytic cave.  (3) Binding of a second molecule of DAG or PMA by 
the C1B domain results in unclamping of the kinase and (4) rearrangement of the NFD helix into the 
catalytically competent state, (5) resulting in phosphorylation of target proteins . Modified from Cell 144:55–
66 [33]
For cPKCs, the main trigger for activation is intracellular Ca2+ [21, 86-89]. Intracellular 
Ca2+ is derived either from internal stores or from the external medium. In the case of the 
latter, Ca2+ influx is controlled by many different channels in the plasma membrane 
responding to various stimuli, such as membrane depolarization, agonist binding, or 
intracellular signaling. Ca2+ release from internal stores, mainly from the endoplasmic 
reticulum (ER) or the sarcoplasmic reticulum (SR), is evoked by Ca2+ itself or by signaling 
messengers, such as inositol-(1,4,5)-trisphosphate (InsP3), which is generated from 
hydrolysis of PIP2 by phospholipase (PLC). PLC isoforms can be activated by different 
mechanisms, e.g., PLC" activation by G!q protein through G protein coupled receptors and 
PLC# activation by tyrosine kinase coupled receptors. InsP3 then binds to InsP3R in the ER 
membrane and evokes Ca2+ release from the ER. When intracellular Ca2+ increases, the C2 
domain of cPKCs binds to Ca2+ via its specific Ca2+-binding loop. This binding triggers the 
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conformational changes not only in the C2 domain but also in the C1 domain and the 
pseudosubstrate. Due to the positive charges of Ca2+, binding of the C2 domain and Ca2+ 
rapidly changes the surface charges of the C2 domain from negative to positive. Such a 
switch now allows the protein binding to the negatively charged phospholipids in the inner 
leaflet of the plasma membrane. The Ca2+-induced cPKC plasma membrane targeting is 
quick but weak [87, 88] and the lifetime of membrane-bound cPKC is around 50 ms [90]. 
The interaction of Ca2+ and C2 domain alone is insufficient to fully  activate cPKC, which 
needs more energy.
The natural product of PIP2 hydrolysis by PLC is not only the diffusible InsP3 but also 
membrane-delimited DAG. When cPKC is recruited to the plasma membrane, membrane 
embedded DAG binds to the C1A domain, which results in disengagement of the C1 
domain and eventually forces the full extraction of the pseudosubstrate from the catalytic 
cavity. Simultaneously  following the second binding of DAG to the C1B domain and 
rearrangement of NFD helix in the V5 domain, the cPKC obtains the competent catalytic 
ability  to phosphorylate downstream signaling proteins [33]. Comparing to the phorbol 
esters, although the lifetime of DAG is limited, binding of the C1 domain and DAG still 
provide sufficient energy and time to activate cPKCs [43, 91, 92]. This open conformation 
is then free to bind to co-localized substrates. Once bound to its target, PKC 
phosphorylates Ser/Thr residues based on the primary sequences [93, 94] with an efficient 
enzyme activity, kcat/Km of PKC family ranging in 106 s-1 M-1 [95].
In contrast to cPKCs, the C2 domain of nPKCs is insensitive to Ca2+ due to the absence of 
Ca2+ coordinating residues. The intrinsic affinity  of the C1 domain of nPKCs was 
reportedly sufficient to recognize DAG which may allow a direct recruitment to 
membranes by agonist-evoked levels of DAG [40, 41]. Lipid binding to the C1 domain 
therefore represents a crucial step in the allosteric activation of nPKCs and subsequent 
phosphorylation of nPKC substrates. However, the detailed activation mechanism of nPKC 
isoforms is still unclear.
In addition to the physiological C1-agonist DAG, other chemical compounds especially 
phorbol esters and their derivatives such as PMA display  the potential to directly activate 
PKC isoforms. As described above, both the C1 domain of cPKCs and nPKCs have the 
capability to bind phorbol esters at the level of the plasma membrane. Such a translocation 
exhibits a slower dynamic than that of C2-Ca2+ interaction, but the binding between PMA 
and PKC is strong, which induces much longer residence time on the membrane (200 fold) 
than that of DAG-PKC binding [96], and also provides sufficient energy for allosteric 
activation of PKCs.
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1.3.3 Inactivation of PKC 
The short half-life of DAG is probably the key to terminate PKC signaling or to reverse the 
activation of PKCs, resulting in the membrane-recruited PKC to diffuse back to the 
cytoplasm. It has also been reported that dephosphorylation of activated PKC might be an 
important additional mechanism for inactivation [97]. After PKC’s binding to the 
membrane, the conformation of the protein is open. This open conformation allows 
phosphatases easy access to phosphorylated residues. PKC’s sensitivity  toward 
dephosphorylation is thus increased almost two orders of magnitude [98]. Recently the PH 
domain leucine-rich repeat protein phosphatase (PHLPP) has been identified as one 
member of these phosphatases, which specifically  affects the HM but no effects on TM of 
cPKCs and nPKCs [99]. Most recently, it has been revealed that in MEF cells type 2A 
phosphatase (PP2A)-induced dephosphorylation of the HM  and TM  motif of activated 
cPKCs requires the involvement of an adapter protein named Fas-associated protein with a 
death domain (FADD) [100]. It  should be noted here, however, that although 
dephosphorylation serves as an important switch to turn off the activity of these enzymes, 
dephosphorylation does not necessarily predispose the enzyme to degradation [97]. 
Consistent with this, degradation of PKC can occur through an ubiquitin/proteasome 
pathway that does not involve dephosphorylation of the enzyme [101]. The precise 
mechanisms for inactivation and degradation of PKC isoforms remain to be further 
elucidated.
1.3.4 PKC and protein binding
In addition to the activation of PKC, in particular conventional and novel isoforms, by 
dynamic signaling of DAG or Ca2+, PKC’s activity  is also regulated by a large number of 
scaffold or anchoring proteins. Among these, Mochly-Rosen and coworkers reported a 
series of structurally unrelated scaffold proteins associated to membranes, which were 
named receptors for activated C kinase (RACKs) [102-104]. Briefly, after activation, 
RACK proteins have the ability to recognize and bind individual PKC isoforms and to trap 
them in an activated conformation. Such a binding not only  localizes PKCs but also has the 
potential to sustain PKC activity in the absence of second messenger binding. According to 
this theory, cells apparently  express a unique set  of RACKs with distinct subcellular 
localizations for each PKC isoform. Furthermore, PKC-RACK interactions are essential 
for isoform-specific cellular responses. To date, RACKs have only  been reported for PKC" 
[27, 105, 106], $ [107], and % [108, 109] isoforms, and in each case the respective RACK 
protein is known to serve other functions in addition to PKC binding (Table 1.2).
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Table 1.2 RACK-PKC isoform protein-protein interaction.
PKC isoforms RACK protein RACK binding site
PKC" RACK1 C2 domain / V5 domain
PKC% Annexin V C2 domain
PKC& P32/gC1qBP, RACK2 C2 domain
A kinase anchoring proteins (AKAPs) may provide another example for scaffold proteins, 
which are signaling-organizing molecules that tether enzymes in subcellular complexes to 
control the phosphorylation or dephorsphorylation of neighboring substrates [110]. 
AKAP79, one member of this family, was reported to anchor phospholipid-sensitive kinase 
and PKC on the membrane. Recently, it was reported that the binding of AKAP79 and 
PKC could not only synchronize the intracellular signaling of PKC, but also alter the 
pharmacological profiles of kinase inhibitors [111]. In addition, two putative 14-3-3-
binding motifs have been mapped in the C1B domain of PKC# (Fig. 1.2.2), indicating 
protein-protein interactions of PKCs to 14-3-3 proteins, a family of scaffold protein widely 
involved in signal transduction [112]. The peptides based on these sequences inhibit PKC# 
binding to 14-3-3 in vitro and promote PKC# translocation in vivo [113]. 
The cytoskeleton proteins are another category of molecules, which may bind to PKCs. 
Many cytoskeleton proteins, including tubulin, F-actin, vinmentin, myofibrils, and 
membrane-cytoskeletal cross-linking proteins (MARCKS) [114-116], were found to bind 
to particular PKC isoforms in different cell lines or tissues by using immunocytochemistry 
or co-immunoprecipitation followed by Western blotting. For example, C1 domain of 
PKC% binds F-actin (Fig. 1.2.2, [117]), C1B domain of PKC! interacts with fascin, an 
actin-bundling protein that contributes to cell adhesion and spreading on fibronectin [118], 
and C1A domain of PKC"II binds the centrosomal protein pericentrin to control 
microtubule organization, spindle assembly, and chromosome segregation during cell 
division [119]. Some of these cytoskeletal proteins have also been shown to be substrates 
for PKC [114, 115]. The question whether the interaction between PKC and the 
cytoskeleton is a simple binding or a functional phosphorylation requires further 
investigations.
1.4. Cytoskeleton and diffusion-driven PKC! distribution 
 in Ca2+-induced plasma membrane translocation 
It is well established that following Ca2+ increases cPKCs translocate to the plasma 
membrane via their C2 domain. The detailed mechanism, however, is still unclear and 
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multiple methods were employed to investigate this. Biochemists studied the C2 domain 
membrane association and dissociation in vitro and revealed very fast kinetics for both 
processes [90, 120]. The kon rate for membrane association was around 1010 M-1s-1, while 
membrane dissociation (koff) was still very fast (around 150 s-1) [21, 120]. Compared to the 
Ca2+ dissociation from the C2 domain, koff 12 s-1, they are in a comparable range [90], 
which indicates that Ca2+ unbinding and cPKC membrane dissociation are quasi-
simultaneous. In contrast, the interaction of cPKC’s C1 domain with the plasma membrane 
is characterized by  much slower kinetics. In PKC", for example, kon and koff were measured 
to be 109 M-1s-1 and 0.1 s-1, respectively  [41], which indicates a rather rapid association of 
cPKC isoforms to the plasma membrane, but a slow disassociation.
Fig. 1.4.1 Schematic diagram of two transport models of PKC. (A) Active transport model. Translocation of 
Ca2+ bound cPKCs to the plasma membrane follows a directional movement. The time-dependent 
distribution of PKC along the line labeled in the figure shows a minimum in the center of the cell until the 
equilibrium is achieved. (B) Diffusion-driven movement of cPKCs. Only in the proximity of the plasma 
membrane appears a highly efficient docking of PKCs, resulting in a directional movement that initially 
depletes the subplasmalemmal cytosol. Modified from FASEB J. 15:1634–1636 [87].
Michael Schaefer and colleagues revealed the existence of a transient subplasmalemmal 
depletion zone of cPKC during Ca2+-induced cPKC plasma membrane translocation, which 
implied that the translocation of cPKC followed a diffusion-limited distribution model 
(Fig. 1.4.1 A) instead of an active transport model (Fig. 1.4.1 B) [87]. This model 
accurately explains the process of cPKC membrane translocation. In detail, only in the 
proximity of the plasma membrane the highly efficient association of cPKC to the plasma 
membrane via the Ca2+ bridge may  result  in a directional movement that initially depletes 
the subplasmalemmal cytosol, generating a gradient from the subplasmalemmal to the 
perinuclear cytosol. Later, diffusion equilibrates this gradient, which results in directed 
cPKC translocation from the cytosol to the plasma membrane.
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According to Michael Schaefer’s model, since the diffusion-driven distribution of PKC! 
crossing the cytosol is an essential step of Ca2+-induced PKC! plasma membrane 
translation, a further question arises, whether the cytoskeleton plays any role in such a 
process. Not only working as intracellular scaffolding, cytoskeletal filaments, consisting of 
actin filaments, microtubules, and intermediate filaments, engage in a variety  of 
intracellular transport process, signal transduction, and cell movements [2, 121]. Briefly, 
the actin filaments form long and thin fibers beneath the plasma membrane providing 
mechanical strength to the cell, connecting transmembrane proteins to cytoplasmic 
proteins, and contributing to cell migration. The microtubules are straight and hollow 
cylinders whose wall is made up  of ! and "-tubulin, which are mostly involved in vesicular 
transport and cell division. The intermediate filaments are a family of related proteins with 
an average diameter of 10 nm, responding to mechanical stress. With respect to PKC 
proteins, the interaction between cytoskeleton components and PKCs have been reported 
from time to time (see chapter 1.3.4). Some reports showed that  cytoskeletal components 
were even critical for PKC activation [122-124], Here I applied multiple approaches to 
deeply investigate the process of PKC! translation and test the involvement of the 
cytoskeleton. 
1.5. Self-organized clustering of membrane-bound cPKC
Up to now when introducing PKCs we have only considered association and dissociation 
from the target membrane. cPKCs and nPKCs are believed to be only  active when 
complexed with their respective activators, Ca2+ and/or lipids. It is well established that the 
PKC’s kinase domain is notoriously slow with a turnover rate of only  10 phosphorylation 
events per second [125]. Therefore membrane residence time and target finding of PKC 
proteins appear of utmost importance for our understanding of how PKCs translate Ca2+ 
and lipid messages into phosphorylation events.
Ca2+ signals of much higher complexity, local Ca2+ signals, are established for almost 2 
decades [126, 127] but very little is known on how the cells read-out such Ca2+ signals 
(sparks, puffs, quarks, blips). The very fast association and dissociation kinetics of cPKC 
render them almost an ideal read-out tool for such Ca2+ signals [88, 89]. 
In a previous study [88], we observed series of local translocation events (LTEs) of PKC! 
upon threshold stimulations of Ca2+ mobilization, 5-25 µM ATP in this case. Many of the 
LTEs showed small amplitudes, brief lifetimes, and spatial restrictions following Ca2+ 
signal (Fig. 1.5.1 B). Interestingly, about 15% of LTEs displayed a distinctive 
spatiotemporal pattern (Fig. 1.5.1 A), in particular the lifetime of LTEs was prolonged to 
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more than 4 s, which was almost 5 fold longer than that of the Ca2+ puff, the underlying 
elementary Ca2+ signal with its limited amplitude and spatial spread. Such a phenomenon 
seems to challenge the classic theory of cPKC activation, exhibiting a dissociation between 
the Ca2+ signals and the membrane accumulation of cPKCs. We have to ask ourselves what 
kind of mechanism underlies it. 
Fig. 1.5.1 Spatiotemporal variety of LTEs.  Briefly, the long-lifetime of LTEs in PKC!-eYFP expressing cell 
after ATP stimulation shows in (A) and the short-lived LTEs shows in (B). (Aa and Ba) The blue and green 
plots over time shows the two LTE sites with the relative fluorescence signals respectively. (Ab and Bb) 3D 
surface plots of the fluorescence distribution at selected time points. The two ROI positions are indicated in 
(Ab 1 and Bb 1) respectively. (Ac and Bc) The 3D surface plots show the spatial dimension of LTEs by he 
3D surface pseudo-linescan. The lines are marked in (Ab 4 and Bb 2) respectively. Taken from J. Cell Biol. 
174:521–533.[88]
It is also important to understand this because such long-lived cPKC translocation could be 
a key to understand how cPKC decode local Ca2+ signals into phosphorylation events since 
such translocation of cPKC with a long lifetime would give the kinase enough time to 
target and phosphorylate their substrates. 
In addition, I was interested in the specificity  of this phenomena, whether this is a unique 
behavior of PKC! or it may occur during other cPKCs translocation. Even other C2 
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domain containing proteins, e.g., cPLA, synaptotagmin, CAPRI, and so on, possessing the 
characteristic of Ca2+-dependent plasma membrane targeting [128-130] could also respond 
to local Ca2+ events. 
1.6. C-domain toolkit of PKC decoding spatiotemporal 
 signal
So far, may  studies have reported that temporal differences of the cPKC and nPKC 
isoforms responses to complex Ca2+ and/or lipid signals in the velocity  of translocation to 
the plasma membrane. Following activation of G!q-coupled receptors or phorbol esters 
such as PMA, the plasma membrane has been identified as the major cellular target of 
PKCs [131-133]. Nevertheless, with respect to the similarity of consensus sequence for 
phosphorylation [16, 93, 94], how these different PKC isoforms decode the variety  of 
incoming messengers into phosphorylation events appears to be instrumental for the 
understanding of many signaling mechanisms in cells.
In general, the specificity of phosphorylation events achieved by PKCs results from 
specific targeting rather than from substrate specificity [20, 22]. Presently, there are two 
conflicting models that try to explain how PKCs target  specifically. One assumes that 
specific PKC targeting is a result of PKC binding to RACK proteins, which decide the 
final location of activated PKCs [103, 104, 108]. The other model suggests that PKC 
targeting is driven by signaling molecules, such as Ca2+ and lipid derivatives, which bind 
to the C1 and/or C2 domain of PKCs, particularly  cPKCs, and trigger the translocation of 
PKC to the plasma membranes [22, 43, 86, 91].
With respect to PKC proteins themselves, in vitro studies have shown that the membrane 
targeting domain of PKCs has distinct preference for different membranes due to their 
phospholipid compositions [134-136]. Particularly  the C1 domain of PKCs can distinguish 
DAGs based on their particular fatty  acid composition [38, 86, 136]. It was also reported 
that unsaturated fatty  acids alone may be sufficient for nPKC translocation to intracellular 
membranes [137], which highly indicates that  specific lipids might determine or modulate 
PKCs targeting.
Using confocal microscopy of living cells, I aimed to address the following questions: (i) 
what are the translocation patterns of nPKCs (e.g., PKC$) in comparison to those of 
cPKCs (e.g., PKC!) following the physiological activation of endogenous G-protein-
coupled signaling pathways; (ii) which cellular membranes are targeted by cPKCs and 
nPKCs; (iii) which domains of PKC molecule account for its particular translocation 
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pattern; (iv) what are the underlying signaling cascades leading to the specific membrane 
targeting; (v) whether translocation leads to phosphorylation at the target membrane; (vi) 
and what are the physiological consequences of specific membrane targeting.
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Chapter 2 
MATERIAL AND METHODS
2.1 Material 
2.1.1 Chemical compounds and solutions
Chemical compounds ATP, Bryostatin 1, 8-pCPT-2’-O-Me-cAMP, U37122, PMA, 
Ionomycin, Cytochalasin D (Cyto-D), and Nocodazole were purchased from Sigma-
Aldrich (Munich, Germany). m-3M3FBS and Gö6983 were purchased from TOCRIS 
(Bristol, United Kingdom). ci-InsP3/PM was purchased from SiChem (Hamburg, 
Germany). NP-EGTA/AM, Fura-2/AM, Fura-red/AM  Fluo-4/AM, Indo-1/AM, and 
Pluronic® F127 were purchased from Life Technologies (Darmstadt, Germany).
Dulbecco’s modified Eagle’s medium (DMEM), Fetal bovine serum (FBS) and Pen-Strep 
(containing 10,000 U/ml penicillin and 10,000 µg/ml streptomycin) were purchased from 
Life Technologies (Darmstadt, Germany). Trypsin-EDTA (1x) was purchased from PAA 
(Cölbe, Germany). Transfection reagent NanoJuice® and Lipofectamine 2000® were 
purchased from EMD Millipore (Darmstadt, Germany) and Life Technologies (Darmstadt, 
Germany), respectively.
Tyrode solution consists of 135mM NaCl, 5.4 mM KCl, 2mM  MgCl2, 10mM  glucose, and 
10mM HEPES in pH 7.35. Modified Tyrode solution, containing 137 mM LiCl, 5.4 mM 
KCl, 2 mM MgCl2 10 mM  EGTA, 10 mM glucose, and 10 mM EPES in pH 7.35 was 
applied in the assays specially indicated.
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2.1.2 Enzymes and kits for molecular cloning
The restrict endonucleases, EcoRI, EcoRV, BglII, KpnI, MluI, XbaI, and XhoI, and T4 
ligase were purchased from Fermentas (St Leon-Rot, Germany). The high fidelity DNA 
polymerase, Phusion® Hot Start  II was purchased from Thermo Fisher (Bremen, 
Germany). The DH5! competent cells were provided by  Ms. Tanja Kuhn for plasmids 
transformation and amplification. The plasmid mini- and maxi-preparation kits and DNA 
gel extract kit, QIAquick® were purchased from Qiagen (Hilden, Germany).
2.1.3 Small interfering RNA
The human small interfering RNA (siRNA) structures, Epac1 siRNA (Catalog No. 
L-007676-00-0005), scrambled siRNA (Catalog No. D-001810-01-05), and transfection 
indicator, siGLO RED (Catalog no. D-001630-02-05), were purchased from Thermo 
Scientific (Bremen, Germany).
2.1.4 Primers
All DNA primers were synthesized by  Life technologiesTM and diluted with RNase free 
water to 100 µM stocked in -20°C. 
2.1.5 DNA vectors and fluorescent labeled proteins
The plasmids, pcDNA3-PKCa_GFP (Fig. 2.1.1 A) and pcDNA3-PKCd_GFP (Fig. 2.1.1 
B), encoding human PKC! and PKC$ proteins fused with C-terminal eGFP, were kindly 
gifted from Prof. Michael Schaefer [133], which contain EcoRI recognized site in front of 
the initiation codon ATG of PKC and EcoRV/XhoI recognized site in front of the initiation 
codon of eGFP in the same ORF (Fig. 2.1.1). Other plasmids encoding PKC! fused with 
N-terminal eYFP, CFP or DsRed2 based on pcDNA3 were constructed by Dr. Gregor 
Reither with the same EcoRI and EcoRV/XhoI recognized set. Human PKC! is also fused 
to N-terminal TagRFP-T [138] based on a pCR259 vector (MP Biomedicals, Eschwege, 
Germany) by Dr. Anke Scholz with the EcoRI and EcoRV recognized set (Fig. 2.1.1 C). 
The mammalian bidirectional expression vector, pBI-CMV1, was purchased from Clontech 
(Mountain View, United State) (Fig. 2.3.3 A). 
The fusion protein labeling the endoplasmic reticulum was construct from a sequence of 
calreticulin at the 5’ end of DsRed2 and the KDEL ER-retention sequence at the 3’ end of 
DsRed2, which was cloned from the commercial vector, pDsRed2-ER (Clontech, 
Mountain View, United State), and inserted to the pCR259 vector. The probe labeling 
Golgi was constructed with the N-terminal 81 amino acids of human beta 1,4-
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galactosyltransferase, obtained from the commercial vector pECFP-Golgi (Clontech, 
Mountain View, United State), and fused with C-terminal mRFP into the pCR259 vector. 
The mitochondrial labeling protein was generated from subunit VIII of human cytochrome 
c oxidase, cloned from the commercial vector pDsRed1-Mito (Clontech, Mountain View, 
United State), and fused with C-terminal mRFP into the pCR259 vector. These plasmids 
were constructed by Dr. Sandra Ruppenthal.
Fig. 2.1.1 Map of plasmids encoding fluorescent labeled PKC proteins. The sites recognized by restriction 
endonuclease are labeled. The open reading frames are indicated with respective colors. 
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The FRET based PKC activity probes, CKAR and PM-CKAR, were a kind gift of Prof. 
Alexandra Newton [139]. The plasmid mVenus-b(5) was supplied from Prof. Nica Borgese 
[140], which contained an ER-resident sequence, 20 amino acids of transmembrane 
domain of cytochrome b(5) with polar sequence. pCMV2-FLAG-RapGAP1 plasmid 
encoding human Rap1GAP protein was kindly provided by Prof. Lawrence Quilliam 
[141]. 
2. 2 Microscopy devices
2.2.1 Video-imaging system (TILL Photonics Imago)
The Imago microscope system was based on an inverted microscope (TE-2000, Nikon, 
Düsseldorf, Germany) equipped with a CCD camera, Imago-QE (TILL Photonics, 
Gräfelfing, Germany). A monochromator, Polychrome IV (TILL Photonics, Gräfelfing, 
Germany) was used to generate the desired excitation wavelengths, which were reflected 
by a suitable dichroic mirror and focused onto the cells with a 20x multi-immersion 
objective (NA 0.75, Plan Fluor, Nikon, Düsseldorf, Germany). The Digital Signal 
Processor (DSP)-driven Imaging Controlling Unit (ICU, TILL Photonics, Gräfelfing, 
Germany) controlled the camera and the monchromator and was operated by software 
TILLvisION v4.0 (TILL Photonics, Gräfelfing, Germany).
2.2.2 Confocal microscope (Leica TCS SP5)
The Leica TCS SP5 II (Leica Microsystems, Wetzlar, Germany) was based on an inverted 
epifluorescence microscope with a resonating x-scanner at a full speed of 8000 Hz. For 
excitation of eGFP, Fluo-4 with 488 nm and DsRed2, TagRFP-T with 514 nm spectrum, an 
Argon gas laser was employed. The laser line selection was controlled by a computer 
operated Acousto-Optic Tunable Filter (AOTF). The design of the confocal microscope 
allowed the selection of emission spectrum in a filterless mode by an Acousto-Optic Beam 
Splitter (AOBS) that substitutes the primary dichroic mirror. Photon detection was 
performed with a two-channel high sensitive SP prism spectrometer. The entire confocal 
system was controlled by Leica Application Suite software (ver. 2.4).
2.2.3 Kilobeam scanning confocal system (VisiTech-VTinfinity) 
The VT infinity  confocal microscopy was based on an inverted microscope (Eclipse TE 
2000-U, Nikon, Düsseldorf, Germany) equipped with a kilobeam 2D-array scanner (VT 
Infinity, VisiTech International, Sunderland, United Kingdom), which enabled fast 
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acquisitions of two-dimensional images by guiding a bundle of excitation beams to the 
specimen via a galvanometer scanner and the emission beams through pinhole-arrays 
towards the detection device (Fig. 2.2.1). Different lasers (Cobolt, Solna, Sweden) supplied 
a selection of wavelengths and were controlled by an AOTF. A cooled EM-CCD-camera, 
iXon 887 (Andor Technologies, Belfast, United Kingdom), was employed for signal 
detection. The whole setup was integrated and controlled by VoxCellScan software 
(VisiTech International, Sunderland, United Kingdom). 
Fig. 2.2.1 Illustration of the kilobeam scanning confocal microscopy. The green lines indicate excitation 
laser light, the red lines show emission light, and the blue line illustrates the FRAP beam path. Adapted 
from Kaestner, L.  Calcium signaling. Approaches and Findings in the Heart and Blood. (Springer: 
Heidelberg, 2013).
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2.3 Methods
2.3.1 Recombination of the chimera constructions
In order to investigate the biological function of each regulatory domain of cPKCs and 
nPKCs, eight chimeras were constructed by mutually exchanging regulatory domains of 
PKC! and PKC$, as shown in Fig. 2.3.1, and fused with the C-terminal fluorescent protein 
eGFP.
Fig. 2.3.1 Structure of chimeras. The original structures of PKC! domain are in cyan color, while the original 
structures of PKC" domain are in green color.
The desired regulatory  domains of PKC! and PKC$ were amplified individually by PCR 
from full-length wild-type PKC! and PKC$. Briefly, in case of Chimera IV (ChimIV), the 
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PCR primer pairs, Forward-! x ChimIV-1, ChimIV-2 x ChimIV-3, and ChimIV-4 x 
Reverse-1 were used to generate three fragments of Chimera IV, including the 5’ of PKC!
with the C1 domain, the C2 domain of PKC$ and the 3’ of PKC! with kinase domain. With 
the oligonucleotides, overlapping sequences were introduced in each of the fragments. 
During the second round of PCR amplification, the three fragments were used as template 
to amplify  full-length Chimera IV with the pair of primers Forward-!, containing an EcoRI 
recognized site, and Reverse-1, containing a XhoI recognized site (Fig. 2.3.2). This two-
step PCR is well discussed by Yokoyama and colleagues [142]. All other chimeras were 
generated in this way utilizing the respective pairs of primers listed in Table 2.1. In PCR 
process, high fidelity DNA polymerase was used and the annealing temperature of each 
PCR was set according to the lowest melting temperature of the primers. 1% agarose gel 
was used for DNA electrophoresis and the proper molecular size of PCR products were 
retrieved by a DNA gel extract  kit following the manufacturer description. The purified 
chimera fragments were double-digested by restriction endonucleases, EcoRI and XhoI. 
With the EcoRI and XhoI sites the chimera fragments were inserted back into pcDNA3 
together with eGFP as described above (Fig. 2.1.1). The correct  construct of all chimeras 
was confirmed by DNA sequencing.
Fig. 2.3.2 Scheme of chimera construction. Briefly, KC" C2 domain, PKC! C1 and kinase domain can be 
amplified by the indicated pair of primers with short linkers. Then the second round of PCR connect the 
separated domain fragments with the linker. The primers are listed in Tab. 2.1.
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Table 2.1 The list of primers for PKC Chimeras construction
Name Sequence 5’-3’
Forward-% TGGAATTCGCCCTTCCCACCAT 
Forward-! AGAATTCGCATGGCTGACGTTTTCCCG 
Reverse-1 ATCTCGAGCGGCCGCCAGTGTG
ChimI-1 AGCGCGCGATGAATTTGTGGTTCTTGATGTAGTGGATTTTGGCC
ChimI-2 GGCCAAAATCCACTACATCAAGAACCACAAATTCATCGCGCGCT
ChimI-3 CCAAAAGCTTCTGGTTGATGCCGCAGAGGCTGGGGACATTGAT
ChimI-4 ATCAATGTCCCCAGCCTCTGCGGCATCAACCAGAAGCTTTTGG
ChimII-1 TAAATCCGCCCCCTCTTCTCGAACGGCGCCATGGTGGGAA
ChimII-2 TTCCCACCATGGCGCCGTTCGAGAAGAGGGGGCGGATTTA
ChimII-3 TTGTTTGCAATCCACGTCCTCCCCTTCCGGAATGGGTACG
ChimII-4 CGTACCCATTCCGGAAGGGGAGGACGTGGATTGCAAACAA
ChimIII-1 AGGTGGCGATAAACTCATGGTCCTTCACCTCGTGCACG
ChimIII-2 CGTGCACGAGGTGAAGGACCATGAGTTTATCGCCACCT
ChimIII-3 CTCAGTGTGATCCATTCCGCAGAGGTTGGCCACCTTC
ChimIII-4 GAAGGTGGCCAACCTCTGCGGAATGGATCACACTGAG
ChimIV-1 GAGTTGAAGGCGATGCGCAGAGTGTGATCCATTCCGCAGA
ChimIV-2 TCTGCGGAATGGATCACACTCTGCGCATCGCCTTCAACTC
ChimIV-3 TCCATGTTTCCTTCCTCGTCCAGGAAATACTGAACAGACA
ChimIV-4 TGTCTGTTCAGTATTTCCTGGACGAGGAAGGAAACATGGA
ChimA-1 The same as ChimIII-1
ChimA-2 The same as ChimIII-2
ChimA-3 CAAGATCATCGGCAGATGCCCGGGTGCGGATAAGGGAC
ChimA-4 GTCCCTTATCCGCACCCGGGCATCTGCCGATGATCTTG
ChimB-1 GCTGTTGGCCGCGGTGCCAGTACAAGAAA
ChimB-2 TTTCTTGTACTGGCACCGCGGCCAACAGC
ChimB-3 The same as ChimIII-3
ChimB-4 The same as ChimIII-4
ChimC-1 The same as ChimI-1
ChimC-2 The same as ChimI-2
ChimC-3 GTTGGCCGCGGTGCCAGTACAAGAAAAAGTAACAAATTCATG
ChimC-4 CATGAATTTGTTACTTTTTCTTGTACTGGCACCGCGGCCAAC
ChimD-1 GTGTGGATTTTGAACTTGTGCGGCATGTCGATGTTGAAG
ChimD-2 CTTCAACATCGACATGCCGCACAAGTTCAAAATCCACAC
ChimD-3 The same as ChimI-3
ChimD-4 The same as ChimI-4
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2.3.2 PKC" mutagenesis
In human PKC$, sited-direct mutations were performed by a similar two-step PCR 
protocol as described above. Primers containing specific mutations were synthesized 
according to Table 2.2. In the first PCR, the forward primer, Forward-$ (listed in Tab. 2.1), 
paired with the reversed version of mutation oligo and the forward version of mutation 
oligo paired with the reverse primer, Reverse-1 (listed in Tab. 2.1), amplified the 5’-half 
and 3’-half PKC$ respectively. Taking advantage of the sequence overlapping around the 
mutation place, the two fragments working as template can be linked by the second round 
of PCR with the forward and reverse primers, Forward-$ and Reverse-1. Following the 
similar steps described above (chapter 2.3.1), the DNA fragment of single amino acid 
mutated PKC$ was inserted back to the pCDNA3 backbone fused with eGFP. All PKC$ 
mutants were confirmed by DNA sequencing.
Table 2.2 List of primers for PKC" mutations
Mutant position Sequence 5’-3’
W252K TGCGGCAGCCTGCTCAAGGGACTGGTGAAG
K378R GGAGAGTACTTTGCCATCAGGGCCCTCAAGAAGGATGTG
T507E AGAGCCGGGCCAGCGAGTTCTGCGGCACCC
Due to the same open reading frame of PKC$ and PKC! with the same EcoRI and EcoRV 
restrict sites in the plasmids pCDNA3-PKCa-eGFP and pCR259-PKCa-Tag, it  was 
convenient to change the included fluorescent protein from eGFP to TagRFP-T by double-
digesting the fragment of wild type or mutated PKC$ from one vector and inserting it to 
another (Fig. 2.1.1).
2.3.3 Construct of PKC"-eGFP and Rap1GAP co-expression vector
The mammalian bidirectional expression vector, pBI-CMV1 allows expression of two 
proteins of interest duo to its two constitutively active promotors that located just upstream 
of two independent multiple cloning sites (MCS) (Fig. 2.3.3 A). Using PCR technique, 
PKC$-eGFP and Rap1GAP were amplified from plasmids pcDNA3-PKCd_GFP and 
pCMV2-FLAG-RapGAP1 respectively  by primers (Table 2.3) and inserted into pBI-
CMV1 vector subsequently by  pairs of restriction endonucleases, MluI and EcoRV for 
Rap1GAP at  MCS 1, EcoRI and BglII for PKC$-eGFP at MCS 2 (Fig. 2.3.3 B). The 
plasmid pBI-Rap1GAP-PKCd-eGFP was confirmed by DNA sequencing. 
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Table 2.4 Primers for vector pBI-Rap1GAP-PKCd-eGFP
Name Sequence 5’-3’
Rap-Forward CTGACGCGTATGATTGAGAAGATGCAGG
Rap-Reverse TATCGATCTAACAGCCCAGCTGGGG
PKCd-FW TGGAATTCGCCCTTCCCACCAT 
PKCd-RV GGAGATCT CTAGCATTTAGGTGACAC 
Fig. 2.3.3 Scheme of the bidirectional expression vectors. (A) The map of original pBI-CMV1 vector. (B) 
The map of plasmid pBI-Rap1GAP-PKCd-eGFP. The open reading frames of Rap1GAP, PKCd,  and eGFP 
are indicated with red, yellow, and green respectively.
2.3.4 Generation of the ER localized CKAR
The ER targeted PKC specific activity  probe (erCKAR) was constructed based on the 
plasmid pcDNA3-CKAR by  fusing the ER targeting sequence, 20 amino acids of 
transmembrane domain of cytochrome b(5) with polar sequence, to the C-terminal of 
CKAR, which endow the fused protein specifically facing towards the cytoplasmic side of 
the ER rather than the ER luminal side [143, 144]. 
For this synthesis, I made use of KpnI and XbaI in the original plasmid pCDNA3_CKAR 
(Fig. 2.3.4), and amplified the part of the CKAR from the N-terminus of the FHA2 motif 
to the C-terminus of YFP, by employing the ER-Forward primer (Tab. 2.4) and the 
synthesized oligo linker, Linker-RV (Tab. 2.4), which consists of the C-terminus of CKAR 
and the N-terminus of the ER targeting sequence. The ER targeting sequence was 
amplified from N-terminus by the synthesized oligo linker, Linker-FW (Tab. 2.4), the 
reverse and complement of Linker-RV, to the C-terminus by the primer ER-Reverse with a 
XbaI site (Tab. 2.4). The second step  of PCR linked the part of the CKAR and the ER 
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targeting sequence together by the primers ER-Forward and ER-Reverse. After double-
digestion, the erCKAR fragment was inserted back into the pCDNA3_CKAR plasmid and 
named with pCDNA3_CKAR-ER (Fig. 2.3.4). The plasmid was confirmed by  DNA 
sequence.
Table 2.4 Primers for DNA plasmid ER-CKAR
Name Sequence 5’-3’
ER-Forward CTGGTACCAAGGGTAATGGT
ER-Reverse GATCTAGACCGGAATTCTCA
Linker-FW GCATGGACGAGCTGTACAAGAAGCTGATCTCTGAGGAAGA
Linker-RV TCTTCCTCAGAGATCAGCTTCTTGTACAGCTCGTCCATGC
Fig. 2.3.4 Scheme of erCKAR generation. Briefly, the ER location sequence and FHA2-YFP fragment were 
amplified from mVenus b(5) plasmid and pcDNA3_CKAR plasmid with a linker, respectively.  The second 
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round of PCR links the two fragments with a designed pair of primers. Finally the fragment inserts back with 
the ER location sequence.
 2.3.5 Cell culture and transfection
The human embryonic kidney 293 (HEK293) cell line was maintained in DMEM with 5% 
(v/v) FBS, 100 U/ml penicillin and 100 µg/ml streptomycin at 37°C in 5% CO2 in an air 
humidified incubator. Before the day of transfection, cells were plated on 20 mm diameter 
glass coverslips in a 12-well plate at about 30% confluence.
For the DNA plasmid transfection, NanoJuice® was applied, which comprised two 
chemical reagents, Core transfection reagent  and Booster. Main steps of operation are 
listed; 
1)  Preparing a master mix for all desired wells and mixing it thoroughly; 
 For each well of a 12-well plate: 50 µl DMEM (without antibiotics)
         0.5 µl Core transfection reagent
            1 ,l Booster 
2)  Incubation of the reagents and medium mixture at room temperature for 5 min;
3)  Preparing plasmid tubes for different DNA or DNA combinations, 
     1 µg of total mount of DNA plasmid per well;
4)  Adding the reagents and medium mixture to the plasmid tube and mixing gently;
5)  After incubation at room temperature for 20 min, 50 µl of mixture per well was dropped 
to the cells evenly;
6)  Cells were maintained in the incubator at 37°C and 5% CO2 for 48 h.
In DNA plasmids and the siRNA co-transfection assay, Lipofectamine 2000® was utilized. 
Main steps of operation are listed; 
1)  Preparing a master mix for all cells and mixing it thoroughly;
2)  For each well of a 12-well plate: 50 µl DMEM (without antibiotics)
     2 µl Lipofectamine 2000®
3)  Incubation of the reagents and medium mixture at room temperature for 5 min;
4)  Dilution of plasmid and siRNA with DMEM (without antibiotics), 1 µg of DNA 
plasmid, 5 µl siRNA (20 nmol), and 2 µl siGlo (0.1 nmol) in 50 µl DMEM per well;
5)  Incubation of the mixture of reagents and siRNA at room temperature for 20 min;
6)  Removing the complete medium from cell culturing wells and gently adding the 
transfection mixture;
7)  After incubation at 37°C and 5% CO2 for 6 h, replacing the HEK293 cell complete 
medium and keeping in incubator for another 72 h.
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2.3.6 Immunocytofluorescence labeling of actin filaments
When HEK293 cells reached about 40% confluence, they were fixed in 4% 
paraformaldehyde (in PBS) for 10 min. After a wash step with PBS, the fixed cells were 
permeabilized with 0.1% Triton X-100 (in PBS) for 10 min. After a PBS wash step, 5% 
BSA in PBS was used for blocking unspecific binding for 20 min at room temperature. For 
actin filament staining, 0.5 µM ATTO-647N phalloidin (Atto-Tec, Siegen, Germany) was 
employed in 1% BSA of PBS at room temperature for 2 h. After washed with PBS for 3 
times, the cells were mounted in ProLong Gold Antifade reagent and visualized by 
confocal microscopy.
High-resolution images were acquired by the TCS SP5 II confocal microscope with a Plan 
Apo 63x oil immersion objective (Leica, Wetzlar, Germany). The excitation was achieved 
at 635 nm and fluorescent emission was collected in the spectral range of 648 to 750 nm.
2.3.7 Confocal imaging of living cells on Leica TCS SP5
Coverslips with HEK293 cells were mounted in custom-made chambers and bathed in 
Tyrode solution. The chamber was mounted on the stage of the microscope. The bath 
solution was rapidly  changed by  means of pipetting and liquid suction. The volume of the 
reservoir was about 400 µl. Confocal images were recorded with the TCS SP5 II 
microscopy using a 63-, NA 1.4, Plan-Apo oil immersion objective (Leica, Wetzlar, 
Germany). Excitation was achieved with appropriate excitation wavelengths, 488 nm for 
eGFP or 561 nm for mRFP, DsRed2, and TagRFP-T. The respective emission was captured 
at 495-550 nm for eGFP and 600-750 nm for mRFP, DsRed2, and TagRFP-T. 1024x1024 
pixels images were recorded at 0.2 frames per second (fps). When necessary, Fura-red/AM, 
a cell membrane-permeable Ca2+ indicator with excitation at  450-500 nm and emission at 
around 660 nm, was employed to monitor Ca2+ transient  with PKC!-eGFP translocation 
simultaneously. Fura-red/AM  was stored in a stock solution at 1 mM  in DMSO containing 
20% Pluronic F-127 and finally diluted to 1 µM with Tyrode as working concentration. It 
need to note that fluorescence intensity of Fura-Red excited at 488 nm decreases once the 
indicator binds Ca2+. Experiments were performed at room temperature (20-22°C).
2.3.8 Intracellular Ca2+ flash photolysis assay
NP-EGTA/AM, a cell-permeable photo-labile Ca2+ chelator, was stored in a stock solution 
at 1 mM  in DMSO containing 20% Pluronic F-127 and finally  diluted to a working 
concentration of 7.5 µM with Tyrode. NP-EGTA exhibits not only a high selectivity  for 
Ca2+, bur also a dramatic increase of its Kd for Ca2+ (from 80 nM to 1 mM) after 
illumination with UV light. Cells were incubated with NP-EGTA/AM for 40 min and 
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allowed 10 min for de-esterification. The VT infinity  confocal microscope was employed 
for image recording through an oil immersion objective (40- NA 1.3 S-Fluor Nikon, 
Düsseldorf, Germany). The desired laser wavelength was selected for excitation of the 
particular fluorescent probe respectively, 491 nm for eGFP, 512 nm for YFP, and 561 nm 
for DsRed2. The fluorescence emission was collected by a 515 nm long-pass filter. Images 
(256x256 pixels) were recorded at 10 fps with 2x2 binning. Ca2+ photolysis was achieved 
by a bright UV flash (TILL Photonics, Gräfelfing, Germany) via a 400 nm long-pass 
dichroic mirror.
2.3.9 Intracellular InsP3 flash photolysis assay
Membrane permeable caged InsP3, ci-InsP3/PM was stored in a stock solution at 1 mM in 
DMSO. Fluo-4/AM was also stored in a stock solution at 1 mM  in DMSO containing 20% 
Pluronic F-127. The cells were loaded with 1 µM  Fluo4/AM and 0.5 µM ci-InsP3/PM  for 
40 min with an additional 10 min for de-esterification. During the experiment, cells were 
pretreated with the required compound for 15 min and bathed in normally Ca2+-free Tyrode 
solution, containing LiCl instead of NaCl. The VT infinity  confocal microscope was used 
for Ca2+ imaging via a 40-, NA 1.3, S-Fluor, oil immersion objective (Nikon, Düsseldorf, 
Germany). Fluo-4 was excited with the 491 nm laser and emission was collected through a 
515 nm long-pass filter. Images (120x128 pixels) were recorded at 2 fps with 4x4 binning. 
Intracellular InsP3 uncaging was performed with a bright UV flash delivered by a 400 nm 
long-pass dichroic mirror. The graded intensity of the UV flash was achieved by multiple 
number of flashes in a short period of time (< 20 ms) but with a constant energy of each 
single flash. The trigger of UV flash and the image acquisition were automatically 
controlled by the software.
2.3.10 Fura-2 based Calcium imaging
The ratiometric Ca2+ indicator Fura-2/AM was dissolved in DMSO containing 20% 
Pluronic F-127 as a 1 mM stock solution and finally  diluted to 1 µM with Tyrode. The cells 
were incubated in the dye solution for 30 min and deesterification was allowed for 10 min. 
A video-imaging microscope (the TILL Photonics Imago system) was used for image 
recording. The monochromator (Polychrome IV, Till Photonics, Germany) was applied for 
alternating excitation of Fura-2 (340 nm and 380 nm) while the emitted fluorescence was 
collected through a 515 nm long pass filter and an oil immersion objective (20x NA 0.75 
Pan-Fluor, Nikon, Düsseldorf, Germany) onto the CCD camera (Imago-QE, TILL 
Photonics, Germany). Image acquisition was performed with 160x132 pixels at 10 fps at 
4x4 binning. ATP stimulation was performed by  means of a solenoid-driven custom-made 
perfusion system, which provided a laminar flow of about 200 µm in which all cells were 
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contained. A change of solution was achieved rapidly by opening and closing of 
appropriated solenoids. 
2.3.11 Förster resonance energy transfer (FRET) 
Experiments were performed on the TILL Photonics Imago video-imaging microscope 
with cells expressing FRET probes. A monochromator, Polychrome IV, was used for 
excitation CFP of 430 nm and YFP of 512 nm. The excitation light  was reflected via a 
CFP/YFP double dichroic mirror through an oil immersion objective (20x NA 0.75 Pan-
Fluor, Nikon). The emitted fluorescence was separated into two channels, 475/24 nm for 
CFP-channel and 535/30 nm by an image splitter with a CFP/YFP FRET filter-set 
(OptoSplit II, Cairn Research, Kent, United Kingdom) and simultaneously recorded with a 
single CCD. Images (160x240 pixels) were acquired at 0.1 fps with 2x2 binning. During 
the experiment, the extracellular solution was quickly changed by means of a pipette and 
liquid suction. To redress the spectral excitation and emission cross-talking, cells 
expressing YFP and CFP respectively  were measured in the condition described above to 
obtain the acceptor relative fluorescent signal ! and donor crosstalk fraction ". 
Where desired, the FRET measurements were also combined with recordings of 
intracellular Ca2+ in CFP and YFP co-expressing cells. The Ca2+ dye Indo-1/AM was 
stocked in DMSO containing 20% Pluronic F-127 at 1 mM and finally diluted to 2 µM 
with Tyrode prior to the experiment. The cells were incubated with Indo-1/AM for 40 min 
and deesterification was allowed for 10 min. Three alternating excitation wavelengths, 350 
nm for Indo-1, 430 nm for CFP, and 512 nm for YFP, were applied on specimen and 
fluorescence was collected from the same CFP/YFP FRET filterset. The Indo-1 signal was 
collected from two channels, 475/24 nm and 535/30 nm simultaneously, in which the 
signal from the 535/30 nm channel worked as a reference. The other setting rendered the 
same as described above.
2.3.12 Image analysis
The acquired images were stored using OMERO software (OME, Dundee, UK) and further 
analyzed using custom-build macros in ImageJ (W. Rasband, NIH, USA). The 
fluorescence over time data in regions of interest (ROI) were transferred into IGOR 
software (Wavemetrics, USA) and further processed using custom-written macros. When 
necessary, images were de-noised using a wavelet-based algorithm that was recently 
introduced [142, 145] and built into an ImageJ plug-in. Considering inhomogeneous 
distribution of the fluorophores, self-ratio images were calculated where necessary. For this 
purpose, I divided subsequent images of a video by a mean image obtained after averaging 
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the first 10-20 images of the video [88]. Color-coded 2D images were constructed in 
ImageJ from 16-bit or 8-bit grey scale images by  applying the appropriate look-up tables. 
Image correlation analysis was based on Pearson’s coefficient approach using the ImageJ 
plug-in, JACoP (F.P. Cordelieres, Institut Curie, France).
To avoid interference from cell movement, bleaching and spectral excitation and emission 
cross talk, I calculated the apparent FRET efficiency instead of the simple CFP/YFP 
fluorescence ratios according to a method published previously [146] using the following 
formalism:
EfDA
ε
D
ε
A
=
FY CCFPexY FPch − αFY CY FPexY FPch − βFY CCFPexCFPch
αFY CY FPexY FPch ,wit
h FYC being the fluorescence signal of the FRET sensor and CFPex and YFPex referring to 
the excitation wavelength applied and CFPch and YFPch to the emission channels recorded, 
where the acceptor relative fluorescence signal !, 
α =
FY FPCFPexY FPch
FY FPY FPexY FPch , and donor 
crosstalk fraction ", 
β =
FCFPCFPexY FPch
FCFPCFPexCFPch , were obtain by measurement  described in 
chapter 2.3.11. 
2.3.13 Statistical analysis 
When necessary, the values are given as mean values ± S.E.M  (standard error of the mean). 
At the beginning of each statistical analysis the distribution of the values was tested. When 
the values showed a normal distribution, the unpaired two-tailed t test was applied using 
the software Prism 5 (GraphPad Software Inc., USA). The effects were regarded as 
significant only when p value < 0.05. The effects were also presented in the bar graphs, 
one asterisk standing for p < 0.05, two asterisks for p . 0.01, three asterisks for p  . 0.001, 
and N.S. for p / 0.05. The n-numbers were accumulated from more than 3 independent 
experiment and presented in each figure.
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Chapter 3 
RESULTS
3.1 Mechanisms of PKC! translocation
3.1.1 Ca2+-induced redistribution of PKC! to plasma membrane
PKC! activity is evoked primarily by a translocation from the cytosol to the plasma 
membrane directly  following intracellular Ca2+ increases [88]. Therefore the intracellular 
Ca2+ rise is an important step of PKC! activation. Here I utilized the UV-flash to photolyze 
NP-EGTA caged Ca2+ in living cells, which . After loading the cell with 7.5 µM  NP-EGTA/
AM, a membrane-permeable Ca2+ chelator, and Fluo-4/AM, a membrane-permeable Ca2+ 
dye, HEK293 cells were stimulated with 100 µM ATP for 30 s (Fig3.1.1, upper middle) 
allowing to preload NP-EGTA with Ca2+. The UV-flash was uncaging Ca2+ rapidly and 
increased the intracellular Ca2+ concentration within milli-seconds (Fig. 3.1.1, upper right). 
The traces show changes of Ca2+ at the regions indicated. While the red color showed Ca2+ 
recordings within the illuminated region, the blue trace was obtained from a cell outside 
the illuminated area (yellow dashed region). As shown by the images and traces, the 
photolysis approach allows us to restrict UV-excitation to a small part of the field of view, 
increasing Ca2+ inside the illuminated region but without effects on cells outside this 
region (Fig. 3.1.1 upper right, the yellow ring), which provides the advantage to record 
cells under control conditions in parallel. Thus, with characteristics of rapid response, high 
Ca2+ reaction, and spatial restriction of the illuminated region, the UV photolysis of caged 
Ca2+ is proved to be an efficient approach for further studies.
!"
Fig. 3.1.1 Photolysis of caged Ca2+ in living cells.  The fluorescent images (the upper row) show NP-EGTA 
and Fluo-4 loaded HEK293 cells at the indicated times before and after UV-flash. The yellow dash ring 
indicates the flash area (rightmost image). The traces illustrate plots of intracellular fluorescence over time at 
the region of interest,  which are indicated in the upper left image. All data are representative of at least 30 
cells in 3 independent experiments.
For the following studies, the human PKC! fused to eGFP was transiently expressed in 
HEK293 cells (Fig. 3.1.2 A). After NP-EGTA loading, the PKC!-eGFP expressing cells 
were used in the Ca2+ photolysis assay. Following Ca2+ uncaging, the fluorescence at the 
plasma membrane rapidly  increased, while the fluorescence in the cytosol of cells was 
decreasing (Fig. 3.1.2 A), indicating the redistribution of PKC!-eGFP after the Ca2+
increase. The construction of a pseudo line scan clearly presented this dynamic process 
(Fig. 3.1.2 B). Interestingly, the detailed line scan analysis (Fig. 3.1.2 B) revealed that 
immediately after the UV flash, plasma membrane fluorescent increased rapidly while 
nearby  cytosolic regions depicted an initial PKC! depletion. Here, central cytosolic 
regions did not show any  changes at this time point. Only later after the UV flash, there 
was a PKC!-depletion wave engulfing the entire cytosol. During this process the plasma 
membrane fluorescence accumulation continued. In order to appreciate this process, I 
compared fluorescence intensity  from plasma membrane (red trace in Fig.3.1.2 C) and 
from an adjacent cytosolic region (blue traces in Fig. 3.1.2 C). The rapid and antiparallel 
time course of the plasma membrane and cytosolic fluorescence is obvious. 
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Fig. 3.1.2 Quantitative analysis of PKC!-eGFP translocation. (Aa) PKC!-eGFP distribution in HEK293 cells 
at the resting state. (Ab) The relative fluorescent image of PKC!-eGFP upon UV-flash in NP-EGTA loaded 
HEK293 cells at the time points indicated. Scale bar is 10 µm. (B) The pseudo line scan at the labeled 
position (yellow dash line in the panel Ab1). (C) Plots of fluorescence over time at the plasma membrane 
(blue) and the cytosol (green and red) from the regions of interest, indicated with blue green,  and red circles 
in the panel Ab1, close to the yellow dash line. The numbers at the traces correspond to the three images in 
panel Ab. (D) The magnified plot from upstroke trace indicated with the dash box in C was fitted with an 
exponential decay function (red line). 
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Such a representation allowed me to characterize the plasma membrane accumulation 
quantitatively as depicted in Fig. 3.1.2 D. Here, I fitted the membrane accumulation by a 
mono-exponential equation. The most important parameter that could be extracted was the 
time constant of this process, tau (0), characterizing the speed of accumulation, that 
appeared rather independent of the expression level and represented the following 
processes (i) Ca2+ binding to the C2 domain and (ii) binding and accumulation of PKC! at 
the plasma membrane. As mentioned above, subplasma membrane cytosolic regions were 
quickly depleted from PKC! molecules and further accumulation was thus majorly 
determined by diffusion of PKC! from deeper cytosolic compartments.
Considering the important role of the DAG-C1 domain interaction in PKC-membrane 
targeting and the possibility of DAG production from Ca2+-activated Phospholipase C#
(PLC#), I further verified that PKC! translocation was only C2 domain dependent. A 
single amino acid mutation, D256N, located in the C2 domain of PKC! and critical for 
Ca2+ binding [51] was introduced. In Ca2+ photolysis experiments, no plasma membrane 
translocation could be observed in PKC! (D256N)-eGFP expressing HEK293 cells (Fig. 
3.1.3), although the mutated PKC! still translocated to the plasma membrane following the 
treatment with phorbol ester, PMA, (Fig. 3.1.3, right most image). Taking together, I 
confirmed that the Ca2+-C2 domain complex plays a predominant role for Ca2+-induced 
PKC! translocation.
Fig. 3.1.3 The C2 domain of PKC! is essential for Ca2+-induced PKC! translocation. After loading with NP-
EGTA, PKC!(D256N)-eGFP expressed HEK293 cells (left picture) received a UV-flash (middle picture), 
and eventually 500 nM PMA for 20 min (right picture). Pseudo line scan (taken from dashed line in the left 
image, t=0 s) indicates no membrane translocation of PKC!(D256N) upon UV-flash. The black dash lines 
indicate the time of images.
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3.1.2 Dynamics of PKC! translocation
Fig. 3.1.4 DsRed2 tetramer structure. Monomers of DsRed2 are shown in different colors. N- and C-terminus 
of monomer are labeled in respective colors.  Carbon,  nitrogen and oxygen atoms are gray, blue and red, 
respectively. Modified from Nat Biotechnol 22:289–296 [147].
To investigate the sensitivity and reliability of the assay for analyzing the kinetics of PKC!
translocation, I took advantage of the property  of some fluorescent proteins to form 
oligomerized complex, e.g., DsRed2. Due to the hydrophobic interaction between single 
DsRed2 proteins, four DsRed2 form a tetramer with each fused host protein at both N or 
C-terminal locations as depicted in Fig. 3.1.4. Thus, four PKC! aggregate together through 
DsRed2 oligomerization from different angles. Taking advantage of PKC!-DsRed2 
tetramer, I further investigated the kinetic process of PKC! fused to the monomer and 
tetramer fluorescent proteins. Interestingly, following UV photolysis of intracellular Ca2+, 
PKC!-DsRed2 shows slow plasma membrane translocation when compares to the 
monomer form, PKC!-eYFP (Fig. 3.1.5 A, upper images). The traces from the plasma 
membrane and the cytosol illustrate such a difference (Fig. 3.1.5 A, lower lines). The 
statistical analysis of the 0 values of the monomer and tetramer forms of PKC!-FP 
confirmed that the 0 value of the tetramer (2.09 ± 0.192) is almost three times larger than 
that of the monomer (0.75 ± 0.060) (Fig. 3.1.5 C), which is comparable to the reported 
ratio (3.8 ± 0.4) of the hydrodynamic radius of the DsRed2 tetramer to that  of the 
monomer [148]. Therefore the results strongly indicate that during Ca2+-induced PKC!
plasma membrane translocation, the diffusion process is a main contribution to cytosolic 
PKC! transport. 
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Fig. 3.1.5 Dynamic process of PKC! monomer and tetramer translocation. (A) The distribution of PKC!-
DsRed2 and PKC!-eYFP in NP-EGTA loaded HEK293 cells at selected time points in the upper images and 
plots of the relative fluorescence over time at the plasma membrane (blue) and the cytosol (red). Bar is 10 
µm. (B) The diagram shows statistical analysis of upstroke # value on PKC!-DsRed2 and PKC!-eYFP 
expressing cells. 
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3.1.3 PKC! translocation and the cytoskeleton
As described above, numerous reports have suggested that the distribution and localization 
of PKC! depends on the localization and the properties of the cytoskeleton [104, 122-124, 
149]. I thus wondered to what degree the polymerization state of the cytoskeleton might 
affect the translocation properties of PKC! in living cells. For this purpose, I initially 
established experimental conditions that allowed me to study translocation in the presence 
or in the absence of a functional cytoskeleton. In this study, I concentrated on actin 
filaments and microtubules. For both components of the cellular cytoskeleton there are two 
well-known substances that can reliably influence the polymerization state of the 
filaments; (i) Cyto-D for the actin filaments and (ii) nocodazole for the microtubules. In 
preliminary experiments, I established that Cyto-D at a concentration of 4uM  (for 1 h) and 
nocodazole at 5 µM (for 2 h) substantially reduced the ordered arrangement of their 
respective cytoskeleton components, actin filaments and microtubules, as shown in Fig. 
3.1.6. To study the influence of the cytoskeleton on PKC! translocation, I used such 
conditions to substantially reduce filamentous structures in living cells.
Fig. 3.1.6 Effects of Cyto-D and nocodazole on the cytoskeleton. Confocal images of phalloidin stained actin 
filaments in control HEK293 cells (upper left) and Cyto-D treated HEK293 cells (upper right). Confocal 
images of !-tubulin-eGFP expressing HEK293 cells with or without nocodazole treatment (lower row). Bar 
is 10 µm. Similar results were obtained from more than 30 cells in 3 independent experiments.
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Another important set  of control experiments was to test whether depolymerization of the 
cytoskeleton with either Cyto-D or nocodazole could change the property  of Ca2+ uncaging 
by UV-flash photolysis. After loading with NP-EGTA/AM  and Fluo-4/AM and pre-
stimulating with 100 µM  ATP, the Cyto-D or nocodazole pretreated cells were illuminated 
ed with a UV-flash, similar to Fig. 3.1.1. The amplification of Ca2+ uncaging were 
analyzed in the control group, the Cyto-D treated group, and the nocodazole treated group. 
The statistical result shows no significant difference between any of the groups as depicted 
in Fig. 3.1.7, indicating that both compounds didn’t not affect Ca2+ transients triggered by 
photolysis.
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Fig. 3.1.7 Effects of Cyto-D and nocodazole on intracellular Ca2+ photolysis.  The diagram shows statistical 
analysis of Ca2+ photolysis in three groups. Two-tail t-test, n$90 in each group. 
Using Cyto-D and nocodazole at the conditions stated above, I tested the effect of 
cytoskeletal organization on Ca2+-induced PKC! translocation to the plasma membrane. 
The left panels in Fig. 3.1.8 A depict  exemplified confocal images from PKC!-eYFP 
expressing cells before (labeled 1) and following UV flash photolysis of caged-Ca2+
(labeled 2). The time course of the membrane (blue) and cytosolic (red) fluorescence is 
illustrated in the graphs in the right part of panel A of Fig. 3.1.8. These data indicate that 
depolymerziation of actin filaments or microtubules has no significant effects on PKC! 
translocation kinetics. In order to quantify this notion I analyzed a large population of cells 
and characterized the membrane association by determining the upstroke time constant of 
the membrane fluorescence (blue traces). The results of such an analysis are depicted in 
Fig. 3.1.8 B and clearly support the notion that PKC! translocation properties are 
independent of the polymerization state of actin filaments and microtubules.
To summarize the results obtained above, I can draw the conclusion that the distribution of 
cytosolic PKC! to subplasmalemmal in Ca2+-induced plasma membrane translocation is 
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driven by diffusion and it is independent of the main component of cytoskeleton 
components, actin filaments and microtubules.
Fig. 3.1.8 PKC! translocation independent of the depolymerization status of actin filaments or microtubules. 
(A) shows the distribution of PKC!-eYFP at given time points in NP-EGTA loaded HEK293 cells after 
indicated treatment.  The plots of relative fluorescence over time at the plasma membrane (blue) and the 
cytosol (red) correspond to the left images. Scale bars represent 10 µm. (B) The statistical analysis of the 
upstroke time constant # in three experimental conditions. A two-tailed t-test was performed to test for 
significance.
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3.2 Self-organized clustering of membrane-bound cPKC 
3.2.1 Transient interaction of plasma membrane-bound cPKC upon 
 ATP stimuli
It has been reported that cPKCs working as an intracellular Ca2+ signal read-out, responded 
to global Ca2+ signal fast [88, 89]. Application of 100 µM ATP on PKC!-eGFP expressing 
and Fura-red loaded HEK293 cells, global Ca2+ transient was immediately  evoked as 
depicted by the images and the black trace in Fig. 3.2.1 A, following with a recruitments of 
PKC! to the plasma membrane as depicted by the green traces in Fig. 3.2.1. It  should be 
note that fluorescence intensity of Fura-Red decreases when the indicator binds Ca2+ at 488 
nm excitation. Concomitant with the membrane recruitment, the cytosolic fluorescence 
levels transiently dropped as depicted in Fig. 3.2.1 A, the red trace. Furthermore, 
application of 100 µM ATP in PKC!-CFP and PKC!-eYFP co-expressing HEK293 cells, 
interestingly, I found that the amount of FRET (blue trace in Fig. 3.2.1 B) changed in 
parallel with membrane accumulation (green trace in Fig. 3.2.1 B) when calculating the 
apparent FRET efficiency (see Material and Methods 2.3.12). Even though in this case 
video-imaging system (see Material and Methods 2.2.1) was used to investigate 
intramolecular interactions, ATP-induced PKC! translocation on the plasma membrane 
still could be identified readily  with such a magnitude. This finding shows that when the 
recruitment of PKC! to the plasma membrane occurs, intramolecular FRET substantially 
increases, indicating that during ATP-evoked Ca2+ oscillations, an oscillatory 
intramolecular, intimate interaction between PKC! molecules occurs.
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Fig. 3.2.1 Transient interaction of plasma membrane-bound cPKC upon ATP stimuli. (A) The distribution of 
PKC!-eGFP and fluorescence intensity of Fura-red in HEK293 cell upon ATP stimuli on the given time (left 
panel). The plots over time against relative fluorescence intensity at plasma membrane (green), cytosol (red), 
and intracellular Ca2+ (black) correspond to the left images. The scale bar corresponds to 10 µm. (B) The 
plots over time show the apparent FRET  efficiency (blue) and relative fluorescence intensity at the plasma 
membrane (green) and in the cytosol (red) upon ATP stimulation in PKC!-CFP and PKC!-eYFP co-
expressed HEK293 cells.
3.2.2 Persistent interaction of membrane-bound cPKC following 
 Ca2+ influx
Since application of ATP stimulates G!q-coupled receptors that induce formation of the 
second messengers, i.e. DAG at the plasma membrane and diffusible InsP3 (evoking Ca2+
release), it remains unclear whether this intimate interaction between the membrane 
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localized PKC! molecules is driven by Ca2+ alone or whether DAG binding may  indeed be 
required for such intramolecular interactions. I thus simplified the experimental design by 
limiting plasma membrane recruitment to that  occurring in a Ca2+-dependent manner. For 
this purpose I permeabilized PKC!-CFP and PKC!-eYFP co-expressing HEK293 cells 
with the Ca2+ ionophore, ionomycin [53, 150], and varied the extracellular Ca2+
concentration in order to manipulate intracellular Ca2+ concentration. 
Fig. 3.2.2 Consistent FRET signals with PKC!-membrane binding.  (A) The plots over time show a constant 
apparent FRET  efficiency (blue),  intracellular Ca2+ flux (black) and relative fluorescence intensity on plasma 
membrane (green) and in the cytosol (red) within PKC!-CFP and PKC!-eYFP co-expressed HEK293 cell 
following constant 400 µM Ca2+ and 8 µM ionomycin stimulation. (B) The plots over time show the 
fluctuation of apparent FRET efficiency (blue) and relative fluorescence intensity on plasma membrane 
(green) and in the cytosol (red) in PKC!-CFP and PKC!-eYFP co-expressed HEK293 cell following 
indicated Ca2+ or EDTA stimulation in the presence of 8 µM ionomycin.
Figure 3.2.2 depicts typical results of such an experiment. In Figure 3.2.2 A the HEK293 
cells were additionally loaded with the Ca2+ sensitive fluorescent probe Indo-1, allowing 
simultaneous Ca2+ recordings. Interestingly, solely increasing the intracellular Ca2+
concentration appeares sufficient to induce a robust FRET signal between the PKC!
molecules on the membrane. Please note that for this particular example although I have 
chosen HEK293 cells that allowed clear identification of the plasma membrane after 
translocation even with video-imaging system, fluorescence traces of cytosol and plasma 
membrane were not determined confocally.
In the next set of experiments, I addressed the questions of reversibility and reproducibility 
or refractoriness of the FRET process. For this purpose I rapidly switched between Ca2+-
containing and Ca2+-free (1 mM  EDTA) solutions as illustrated in the typical example 
shown in Figure 3.2.B. It’s clearly illustrated that the FRET process is readily  reversible, 
reduction of the apparent FRET occurred immediately after reducing the intracellular Ca2+
concentration (and PKC! dissociation from the plasma membrane). Moreover rapid re-
addition of Ca2+ resultes in a quick reoccurrence of FRET. These data support my notion 
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that Ca2+ itself is sufficient to cause PKC-PKC interaction and the occurrence of 
intermolecular FRET.
One of the important questions remains, whether the FRET signal I recorded is indeed 
specific PKC-PKC interaction or merely  resulted from unspecific CFP-YFP interactions 
due to molecular crowding [151, 152].
3.2.3 Self-organized formation of membrane-bound cPKC
I gained more insight into this question after analyzing the Ca2+ dependency of the PKC-
PKC interaction process. Fig. 3.2.3 depicts results from experiments in which I used two 
different extracellular Ca2+ concentrations, a moderately lower and a substantially higher 
one (see Fig. 3.2.3 A&B). While the lower Ca2+ gained the same results as described 
before, the higher Ca2+ concentration (around 25 µM) caused a surprising result. The initial 
rapid upstroke of the apparent FRET signal (blue trace in Fig. 3.2.3 B) was followed by a 
spontaneous FRET decrease despite a continuous rise in the Ca2+ concentration (red traces 
in Fig. 3.2.3 A&B). The analysis of a greater population of HEK293 cells (Fig. 3.2.3 C) 
revealed that lower Ca2+ concentrations did not show substantial decay (green bar in Fig. 
3.2.3 Ca), while at higher Ca2+ concentrations the decay time constant was reduced by 
almost 2 orders of magnitude (red bar in Fig. 3.2.3 Ca). Concomitant with this, the 
difference between the peak FRET change and the plateau was significantly larger at high 
Ca2+ (see bars in Fig. 3.2.3 Cb). In order to test whether this spontaneous FRET decay  at 
higher Ca2+ concentration might be due to an unexpected dissociation of PKC molecules 
from the membrane, I analyzed Ca2+ signal, apparent FRET efficiency, and fluorescence 
intensity from cytosolic and plasma membrane PKC! simultaneously and found that a 
decrease of the plasma membrane PKC content was not the reason for the observed decay 
in FRET efficiency  (see Fig. 3.2.3 D). Even though PKC! levels on the membrane were 
constant or even slightly  increasing, the apparent FRET signal peaked and spontaneously 
decayed (blue trace in Fig. 3.2.3 D).
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Fig. 3.2.3 Spontaneous decay of the FRET signal within a constant PKC! membrane binding. (A) The plots 
over time show a constant apparent FRET efficiency (blue) and intracellular Ca2+ (red) in PKC!-CFP and 
PKC!-eYFP co-expressing HEK293 cell following constant stimulation with 800 µM extracellular Ca2+ and 
10 µM ionomycin. (B) The plots over time show a dynamic change of apparent FRET efficiency (blue) and 
intracellular Ca2+ (red) in PKC!-CFP and PKC!-eYFP co-expressing HEK293 cell following constant 2 mM 
extracellular Ca2+ and 10 µM ionomycin treatment.  (C) The bar graphs depict the corresponding statistical 
analysis of the decay time constant (Tau) (a) and the difference between the peak and plateau of the FRET 
signal (b) in high (B) and low (A) Ca2+ concentration. n=37-46 from 4 experiments. (D) The plots over time 
show a constant intracellular Ca2+ flux (black) and relative fluorescence intensity on plasma membrane 
(green) and in the cytosol (red) within PKC!-CFP and PKC!-eYFP co-expressing HEK293 cells but with a 
spontaneous decaying FRET signal (blue) with a persistent 2 mM Ca2+ and 8 µM ionomycin stimulation.
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3.3 C-domain toolkit of PKC decoding spatiotemporal signal
3.3.1 PKC! and PKC" target distinctive compartments of cell 
Due to their lipid-sensitive C1 domains, members of the cPKC and nPKC isoforms can be 
activated by PMA, a widely used member of phorbol esters. By  expressing PKC!, a 
member of the cPKC subfamily, or PKC$, a member of the nPKC subfamily, alone, or co-
expressing PKC$-eGFP and PKC!-TagRFP-T together in HEK293 cells, I investigated 
translocation patterns of these PKC isoforms following PMA stimulation (Fig. 3.3.1). My 
data show that PMA always recruits both isoforms to the plasma membrane and PKC$ also 
to the nuclear envelop due to its nuclear location under resting conditions. I was 
particularly puzzled by  the plasma membrane targeting of both isoforms and asked myself 
how these PKC subfamilies would achieve substrate specificity if they both targeted the 
same membrane. I therefore tested the translocation patterns of these two isoforms 
following physiological stimulation with ATP.
Fig. 3.3.1 PMA-induced PKC translocation. HEK293 cells expressing PKC!-eYFP (upper row), PKC"-
eGFP (middle row) alone, or co-expressing PKC!-TagRFP-T  and PKC"-eGFP (lower row) were treated with 
0.5 µM PMA (at least 22 cells from 3 experiments). Scale bars correspond to 10 µm.
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Fig. 3.3.2 PKC! and PKC" are differentially targeted following ATP stimulation. (A) Representative images 
(left) and plots of the relative fluorescence over time (right). Blue denotes the plasma membrane, and red 
corresponds to the cytosolic fluorescence (see magnified image). (B) Representative images (left) and plots 
of the relative fluorescence over time (right) for two regions of interest. Blue denotes the ER membrane, and 
red corresponds to the cytosolic fluorescence (image 1). (C) Representative images (left) and relative plots of 
fluorescence over time for two regions of interests. The left column of the images displays the resting 
distribution of the PKC constructs while the right column illustrates the increases (green) or decreases (red) 
of the fluorescence relative to the resting condition. The numbers denote the two time points. For the traces, 
blue denotes the plasma membrane (PKC!) or ER membrane (PKC") and red cytosolic fluorescence (for 
both PKCs). Similar data were obtained in 56 cells from 18 independent experiments. Scale bars correspond 
to 10 µm.
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Following ATP stimulation, PKC! responded by rapidly translocating to the plasma 
membrane (Fig. 3.3.2 A). In contrast to that, the PKC$-eGFP displayed a rather different 
behavior following ATP stimulation. With a slow time course PKC$ accumulated on 
intracellular membranes. To verify such differential translocation patterns, I co-transfected 
PKC!-DsRed2 and PKC$-eGFP in the same HEK293 cells and investigated redistribution 
of these PKC isoforms following ATP stimulation (Fig. 3.3.2.C). Similar to my  finding in 
HEK293 cells expressing either of these two isoforms, ATP stimulation of double 
expressing HEK293 cells also displayed a rapid plasma membrane accumulation for PKC!
and a slower recruitment to intracellular membranes for PKC$. It appears noteworthy to 
mention that in several hundred of HEK293 cells analyzed under such an experimental 
condition I never observed a single events of PKC$ translocaton to plasma membrane.
Fig. 3.3.3 Bryostatin 1 specifically recruits PKC" to intracellular membrane. Left images denote the 
fluorescence distribution of PKC" (upper row) and PKC! (lower row) at the time points given. The traces 
depict plots of the intracellular fluorescence over time for PKC! (red) and PKC" (green). Regions of interests 
are indicated in the images and the scale bar depicts 10 µm.
To confirm such a differential translocation of the PKC isoforms, I used an alternative 
compound to active PKC, Bryostatin 1 [153, 154]. Using a concentration of 12 nM, 
Bryostatin 1 selectively and specifically resulted in translocation of PKC$ (green traces in 
Fig. 3.3.3), while in the same cell PKC! did not redistribute at all (Fig. 3.3.3 red trace). 
Thus Bryostatin 1 appears as an alternative and selective tool for evoking PKC$
translocation. 
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3.3.2 PKC" targets the ER-membrane following ATP stimulation
To identify  the subcellular target membrane of PKC$, I co-transfected PKC$-eGFP and 
specific markers of the major three intracellular membrane systems: the endoplasmic 
reticulum (ER, Fig. 3.3.4 A), mitochondria (Fig. 3.3.4 B), and Golgi (Fig. 3.3.4 C) 
respectively. The quantitative analysis of the protein distributions was supported by  the 
generation of co-localization plots before (upper rows in Fig. 3.3.4) and following 10 min 
of ATP stimulation (lower rows in Fig. 3.3.4). While mitochondrial labeling did not reveal 
co-localization in either condition (Fig. Fig. 3.3.4 B) and Golgi-labeling only depicted a 
weak co-localization with very little changes after stimulation (Fig. 3.3.4 C), the co-
localization plots illustrated in Fig. 3.3.4 A (right panels, yellow dash lines) strongly 
suggested the ER-membrane as the main target  of ATP-evoked translocation of PKC$-
eGFP. It appears noteworthy  to mention here, that although the fluorescence plots in Fig. 
3.3.4 A, right depicted a recruitment of PKC$-eGFP (y-axis) to the ER (increase in 
steepness, dashed line), the co-localization was not zero under resting conditions, i.e. 
before ATP application (yellow dash line). Such co-localization indicates that a significant 
portion of PKC$ could be pre-recruited to the ER membrane already under resting 
conditions.
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Fig. 3.3.4 PKC" targets the ER membrane following ATP stimulation. HEK293 cells were co-transfected 
with PKC"-eGFP and different organelle markers,  (A) ER-DsRed2, (B) Mito-mRFP and (C) Golgi-mRFP 
and stimulated with 100 µM ATP. For each condition,  the left columns display PKC" fluorescence, the 
middle columns correspond to organelle fluorescence,  the right columns represent the co-localization 
analysis and the upper and lower row of images were taken before and during ATP stimulation,  respectively. 
Typical examples for 20-30 cells from 3 different experiments. Scale bars depict 10 µm.
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3.3.3 ER recruitment of PKC" is mediated by a cAMP-Epac-PLC% 
 signal pathway
In the following, I addressed the putative signaling pathway resulting in PKC$ recruitment 
to the ER. Purinergic receptors are well known to couple to G!q proteins that stimulate the 
PLC"-InsP3 signaling cascade resulting in plasma membrane limited DAG production. It 
appeared therefore rather unlikely that the G!q-coupled cascade would be responsible for 
translocation of PKC$ to the ER membrane. To elucidate upstream signaling of PKC$ 
targeting, I initially addressed the question whether DAG production at the ER would 
indeed be the trigger for PKC$ redistribution. To achieve that  I utilized the pan-specific 
PLC activator m-3M3FBS and found that general PLC activation was sufficient to cause 
ER-targeting of PKC$ (Fig. 3.3.5 A). In support of this, inhibiting PLCs by  pre-incubation 
with U73122 followed by  application of m-3M3FBS indeed suppressed PKC$ 
translocation (Fig. 3.3.5 B). These data are supportive of the notion that ER-delimited 
DAG production by a PLC is the underlying mechanism for PKC$ recruitment.
A key finding that fostered the compilation of the signaling cascade was the fact that 
following their stimulation some members of the P2Y receptors family were not only  able 
to couple to G!q but simultaneously  also to G!s stimulating the production of cAMP and 
evoking downstream events. At this time the literature did not reveal any possible link 
between cAMP and PKC signaling, I still pursued this route and tested whether increases 
of cAMP were sufficient to trigger ER-targeting of PKC$. The Epac protein, a guanine 
nucleotide exchange factor (GEF), can read out cAMP signals and in addition is able to 
reportedly activate PLC% [155, 156]. I thought of making use of specific cAMP analogues 
that were (i) membrane permeable and (ii) did not preferentially activate PKA in order to 
exclude any effects from PKA. The cAMP analogue, 8-pCPT-2’-O-Me-cAMP, known to 
be inefficient in PKA activation but rather potent in stimulation of Epac [157, 158] made 
this approach rather promising.
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Fig. 3.3.5 PLC is engaged in the targeting of PKC" to the ER. (A) The upper images display the distribution 
of PKC"-eGFP in HEK293 cells upon m-3M3FBS at the time point denoted by the numbers. The blue traces 
denote the fluorescence at the ER membrane, and the red traces represent cytosolic fluorescence. (B) The left 
images denote the fluorescence distribution of PKC"-eGFP in HEK293 cells upon m-3M3FBS and U37122 
at the time points given. The traces depict plots of the intracellular fluorescence over time on the ER 
membrane (blue) and in the cytosol (red).  Regions of interests are indicated in the first images and the scale 
bar represents 10 µm. Similar data were obtained in 20-30 cells from 5 independent experiments.
Fig. 3.3.6 A illustrates a typical result of an experiment in which I stimulated HEK293 
cells expressing PKC$-eGFP with 8-pCPT-2’-O-Me-cAMP. From the data it becomes clear 
that application of the cAMP analogue causes a robust recruitment of PKC$ to the ER. To 
exclude possible unwanted side effects of 8-pCPT-2’-O-Me-cAMP and to confirm its 
specificity in activation of EPAC, I applied specific Epac-siRNA to abrogate Epac 
expression [159]. For this purpose I co-transfected specific anti-Epac siRNA and PKC$-
eGFP in HEK293 cells for 72 h and retested them with 100 µM ATP.
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Fig. 3.3.6 The involvement of cAMP-Epac in PKC" ER recruitment. (A) The left images display the 
distribution of PKC"-eGFP in HEK293 cells upon membrane-permeable cAMP analogue at the time point 
denoted by the numbers. The blue traces denote the fluorescence at the ER membrane, and the red traces 
represent cytosolic fluorescence. (B) The images show distribution of PKC"-eGFP in Epac1 down-regulated 
HEK293 cells (a) and control HEK293 cells (b) upon indicated stimuli at the time point denoted by the 
numbers. The traces depict plots of the corresponding intracellular fluorescence over time for the ER 
membrane (blue) and cytosol (red). Typical examples for 23-28 cells from 4 independent experiments. Scale 
bars depict 10 µm.
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Fig. 3.3.6 B depicts a typical result of such experiments. In contrast  to naive cells in which 
ATP caused ER translocation in 100% of all cells analyzed, it failed to target PKC$ to the 
ER in all cells expressing PKC$-eGFP and Epac-siRNA. Interestingly, application of 
m-3M3FBS to the same cell stimulated PKC$ recruitment to the ER (Fig. 3.3.6 Ba) 
indicating that PLC responsibility for DAG production at the ER membrane was still 
intact. When using scrambled control siRNA for Epac all cells expressing PKC$-eGFP 
showed the translocation of PKC$ to the ER when stimulated with 100 µM ATP. Such data 
supports my  notion that Epac a readout protein for cAMP increases plays an essential role 
in the process of PKC$ ER translocation. Therefore, in the following I addressed the 
possible links between Epac and PLC activation at the ER membrane.
Another thorough search in the literature revealed that for other cell types, the small Ras-
like GTPase, Rap protein not only  can be activated by Epac [160-162], but is also able to 
stimulate distinct PLC isoforms, such as the ER resident PLC% [155, 163, 164]. To test 
whether Rap protein might indeed be the missing link in my signaling pathway, I needed to 
figure out how to specifically activate or inactivate Rap proteins. I thought of applying the 
natural regulator of GTPase activity, the GTPase activating protein (GAP), RapGAP. Thus, 
when over-expressing RapGAP in HEK293 cells the hydrolytic activity  of Rap should be 
substantially  unregulated and should thus substantially  decrease the lifetime of the GTP-
bound active Rap  protein. Such an augmented GTP turnover should consequently down-
regulate or functionally inhibit signaling transduction through Rap [160, 165, 166]. To 
easily identify RapGAP expressing HEK293 cells, the mammalian bidirectional expression 
vector pBI-Rap1GAP-PKCd-eGFP was applied so that all cells expressing PKC$-eGFP 
(green colour) also expressed Rap1GAP. As shown in Fig. 3.3.7 A, cells co-expressing 
PKC$-eGFP and RapGAP were unresponsive to ATP stimulation (Fig. 3.3.7A 1-3 and 
traces below), while application of m-3M3FBS was still potent to cause PKC$ 
redistribution (Fig. 3.3.7A 4-6 and traces below). HEK293 cells transfected with PKC$-
eGFP and the backbone plasmid for RapGAP displayed the normal sensitivity towards 
ATP (Fig. 3.3.7 B). 
All the results presented in this chapter strongly support the existence of a cAMP-Epac-
Rap-PLC% signaling pathway that is responsible for ER-membrane limited DAG 
production and PKC$ recruitment. 
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Fig. 3.3.7 Inhibitory effects of Rap1GAP protein on ATP-induced PKC" recruitment to the ER. The images 
show the distribution of PKC"-eGFP in Rap1GAP over-expressed HEK293 cells (A) and control HEK293 
cells (B) upon indicated stimuli at the time point denoted by the numbers. The traces depict plots of the 
corresponding intracellular fluorescence over time for the ER membrane (blue) and cytosol (red). Similar 
data were obtained in 20 cells from 4 independent experiments. Scale bars depict 10 µm.
62
3.3.4 The C1 and C2 domain of PKC! and PKC" can signal 
 independently of one another
Recruitment of PKC isoforms to their targets relies on their regulatory domains, protein 
binding domains, or their interaction with receptors of activated PKCs (RACKs). To 
explore the various possibilities, I envisaged a novel approach: design of artificial chimeras 
by swapping the C1 and C2 domains of PKC! and PKC$. This design presumed that 
targeting via the C1 and C2 domains would indeed be sufficient to explain the different 
translocation pattern of PKC! and PKC$ based on lipid-protein interactions. To test this, I 
constructed and expressed 4 chimeras (Chimera I-IV) fused to eGFP. To characterize the 
translocation patterns of each chimera, I setup 3 different live-cell assays using (i) 
physiological stimulation with ATP, (ii) Ca2+ uncaging by photolysis, and (iii) stimulation 
with phorbol esters.
A very  interesting set of data was acquired from Chimera III, whose structure is illustrated 
in Fig. 3.3.8, C1 domain of PKC$ in a PKC! backbone. Immediately following ATP 
administration, Chimera III rapidly translocated between the cytosol (Fig. 3.3.8 Ac red 
trace) and the plasma membrane (Fig. 3.3.8 Ac blue trace), reproducing the behavior 
expected from a Ca2+-sensitive PKC. After a more detailed analysis of the image series, I 
found that in addition to this rapid shuttling, Chimera III also displayed a slower, longer 
lasting accumulation at the membrane of the ER. This behavior was never seen from wt-
PKC! and could thus be clearly linked to the inclusion of the PKC$-C1 domain, because 
wt-PKC$ protein accumulated at the ER membrane as detailed in chapter 3.3.1. The two 
additional assays reported the expected behavior for a PKC! backbone with intact C2 and 
C1 domains. Rapid increases of intracellular Ca2+ by flash photolysis of caged-Ca2+ (Fig. 
3.3.8 B) or application of PMA (Fig. 3.3.8 C) recruited the Chimera III to the plasma 
membrane.
A very similar behavior was observed for Chimera II, which based on a PKC$ backbone 
with the C2 domain of PKC!. Following ATP stimulation, Chimera II also rapidly and 
transiently  translocated to the plasma membrane while simultaneous ER accumulation was 
detected (Fig. 3.3.9 A). Results from the caged-Ca2+ photolysis assay (Fig. 3.3.9 B) 
illustrated that for Chimera II sole increases of Ca2+ were sufficient for plasma membrane 
recruitment. Moreover, application of PMA resulted in a long lasting plasma membrane 
and nuclear envelope accumulation of Chimera II as depicted in Fig. 3.3.9 C.
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Fig. 3.3.8 Intracellular distribution of Chimera III following different stimulation regimes.  The domain 
composition of Chimera III structure is shown on the top. (A) Translocation of Chimera III with ATP 
stimulation illustrated both plasma membrane (light blue arrow) and ER (yellow arrow) accumulation. (a) 
and (b) depict representative fluorescence distributions for the time points given. (c) Traces of the 
fluorescence over time for the plasma membrane (blue) and in the cytosol (red). Region of interests are 
denoted in (a). (B) The fluorescence distribution of Chimera III at rest is displayed on the left. The middle 
panel shows relative fluorescence images of the distribution of Chimera III at the time points given. The blue 
arrow indicates the time point of the UV flash. The right traces of the fluorescence over time are taken from 
regions of interest on the plasma membrane (blue) and in the cytosol (red). (C) The fluorescent distribution 
of the Chimera III following PMA stimulation at the time points given. A pseudo line scan was derived from 
the line marked by the yellow dash line.  The green arrow indicates the time of PMA application. Scale bars 
correspond to 10 µm.
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Fig. 3.3.9 Translocation of Chimera II following various stimulation regimes in HEK293 cells. The domain 
structure of the Chimera II is shown on the top. (A) Translocation patterns of Chimera II with ATP 
stimulation in HEK293 cells. The magnified images of the dashed boxes are shown on the upper row. The red 
arrow indicates the time point of ATP application. (B) Fluorescence distribution of Chimera II at rest is 
depicted in the leftmost image. The relative fluorescence images show the distribution of Chimera II at the 
time points given. The lower panel depicts a pseudo line-scan along the desired yellow line in the resting 
image. The red arrow marks the time point of the UV flash. (C) The redistribution of Chimera II following 
PMA application in HEK293 cells at the given time points. Scale bars depict 10 µm.
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Chimera I based on the PKC$ backbone with the C1 domain of PKC!. No translocation 
events was observed either after ATP stimulation or in the Ca2+ photolysis assay, although 
Chimera I still translocated onto plasma membrane and nuclear envelop during PMA 
treatment (Fig. 3.3.10 A). For Chimera IV, which based on the backbone of PKC! but with 
a C2 domain of PKC$, a similar behavior as Chimera I was observed: a lack of response to 
ATP and Ca2+, only  PMA-induced translocation to the plasma membrane could be 
achieved (Fig. 3.3.10 B).
Fig. 3.3.10 Distribution of Chimeras I and IV following PMA stimulation. The images display the 
distribution of Chimera I (A) and Chimera IV (B) upon PMA in HEK293 cells at the pointed time. The 
domain structures of Chimera I and IV are depicted on the top of panels (A) and (B), respectively. Scale bars 
represent 10 µm.
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Table 3.3.1 Summary of the translocation pattern of Chimera I-IV
Name
Do  main Structure
ATP Ca2+ photolysis PMA
C1 C2 Backbone
Chimera I ! % PKC% No response No response Plasma membrane & nuclear envelope
Chimera II % ! PKC% Plasma membrane & ER
Plasma 
membrane
Plasma membrane & 
nuclear envelope
Chimera III % ! PKC! Plasma membrane & ER
Plasma 
membrane Plasma membrane
Chimera IV ! % PKC! No response No response Plasma membrane
Table 3.3.1 summarizes the results obtained for all chimeras. PMA stimulation caused 
translocation of all chimeras to the plasma membrane (see also Fig. 2.3.1). Interestingly, 
those chimeras based on the PKC$ backbone also displayes translocation to the nuclear 
envelope because the PKC$ backbone contains a NLS and is thus also expressed in the 
nucleoplasm [167]. Chimeras I and IV contain PKC$-C2 and PKC!-C1 domains and both 
are incapable of translocating at all following ATP stimulation. Remarkably, ATP 
stimulation evokes the chimeras comprising PKC!-C2 and PKC$-C1 domains to display 
translocation profiles inherited from both C-domains: a rapid and transient phase of plasma 
membrane binding and a slower but more persistent phase of ER accumulation (Fig. 3.3.8 
A and 3.3.9 A). It appears reasonable to assume that the former behavior relies on the 
presence of the PKC!-C2 domain, while recruitment to the ER is a feature attributed to the 
PKC$-C1 domain. From these data, I conclude that the C1 and C2 domains might behave 
as independent members of a signaling toolbox for designing the desired recruitment 
patterns of PKCs. In such a scenario, the intact Ca2+ binding with C2 domain of PKC! 
would always support Ca2+ sensitivity, regardless of the other molecular environment, 
while the contribution of the C1 domain appeares to be much more complex. Despite the 
presence of PKC!-C1 in the Chimera I and IV, I never observed any plasma membrane 
recruitment, although DAG was produced at the plasma membrane following extended 
ATP stimulation [88]. Only when the PKC$-C1 domain was present I observed ER-
targeting (Chimera II and III).
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3.3.5 The C1B domain of PKC" is responsible for ER recognition
The molecular structure of the C1 domain of PKC! and PKC$ are complex, comprising 
C1A and C1B subdomains, each with its characteristic lipid binding profile. To investigate 
which one of these two domains is responsible for the ATP-evoked ER recruitment, I 
constructed four additional chimeras (Chimera A-D) in which I exchanged the C1A and 
C1B domains of PKC! and PKC$ between the backbones of the two isoforms (Fig. 2.3.1). 
After expressing these chimeras with fused fluorescent protein in HEK293 cells, I 
stimulated the cells with 100 µM  ATP and analyzed their translocation patterns. The 
exchange of the C1A domains of PKC! and PKC$ in the reciprocal backbone did not alter 
the behavior of the chimeras, Chimera A still translocated to the plasma membrane only 
and Chimera C was still recruited to the ER membrane (Fig. 3.3.11 A&C). Interestingly, 
the presence of the C1B domain of PKC$ in the PKC! backbone (Chimera B) resulted in a 
transient and rapid plasma membrane recruitment and a more persistent and slower ER 
translocation (Fig. 3.3.11 B), while insertion of the C1B domain from PKC! into the PKC$ 
backbone suppressed any translocation events under ATP stimulation. All these results are 
summarized in Table 3.3.2. 
Table 3.3.2 Summary of translocation pattern from Chimera A-D
Name
 Domain Structure
ATP
C1A C1B Backbone
Chimera A % ! PKC! Plasma membrane
Chimera B ! % PKC! Plasma membrane & ER
Chimera C ! % PKC% ER
Chimera D % ! PKC% No response
To further substantiate my  hypothesis that  the C1B domain of PKC$ determines the ER 
translocation, I designed a PKC$ construct with a single amino acid mutation, W252K in 
the C1B domain of PKC$ that reduced the binding affinity of DAG in vitro [40]. When the 
PKC$W252K expressed in HEK293 cells, the PLC activator, m-3M3FBS, was unable to 
induce its ER translocation (Fig. 3.3.12 A). To confirm the functional integrity of the PKC$ 
C1B binding pocket, I challenged the cells with PMA and found the expected aggregation 
on the plasma membrane (Fig. 3.3.12 B).
Gathering all of these data, I conclude that  the C1B domain of PKC$ determined its ER-
targeted translocation. 
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Fig. 3.3.11 The C1B domain of PKC" is responsible for ER targeting. (A) The domain structure of Chimera 
A and its distribution during ATP stimuli at the time points given. (B) The domain structure of Chimera B and 
its distribution during ATP stimulation. (a) The left image depicts the resting distribution; the right images 
show the relative fluorescence changes at the time points given. (b) ER recruitment at later time points 
(numbers in b correspond to numbers in c). (c) Plots of the relative fluorescence over time on regions of the 
interest indicated in (a). Blue denotes the plasma membrane, green corresponds to the ER membrane and red 
represents cytosolic fluorescence.  (C) The domain structure of Chimera C and its distribution upon ATP 
stimulation in a HEK293 cell at the time point given. Scale bars depict 10 µm.
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Fig. 3.3.12 Effects of mutation in PKC" C1B domain on the ER translocation. (A) The upper rows display 
examples of images of the PKC"W252K distribution at the time points indicated. The lower panels depict 
pseudo line scans constructed from the dashed lines at t=0 min. The scale bars depict 10 µm. (B) PMA 
stimulation was performed 10 min after m-3M3FBS washout in the same cell. Similar data were obtained in 
an additional 22 cells from 9 experiments. The scheme of the mutation position in the C1B domain of PKC"
is shown on the top of the figure.
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3.3.6 PKC phosphorylation at subcellular compartments
The next step was to investigate whether translocation of the PKC isoforms indeed led to 
activation of the kinase activity on their respective target membranes. With respect to the 
spatio-temporal properties of phosphorylation by PKC, the FRET based phosphorylation 
sensor CKAR (C kinase activity  reporter), provided a feasible method to investigate the 
activity of PKC in living cells [139, 168]. In order to study localized phosphorylation 
activity, plasma membrane targeted CKAR (pmCKAR) and ER-targeted CKAR (erCKAR) 
was expressed in HEK293 cells and their location was confirmed by confocal imaging 
(Fig. 3.3.13 A). ER targeting was achieved with the tail-anchor of cytochrome b(5), which 
ensured that the phosphorylation sensor was facing to the cytosol. It should be noted here 
that decreases of the apparent FRET efficiency indicated increases of phosphorylation in 
the FRET probe. In the following, I tested the kinase activity at  the plasma membrane 
(green traces in Fig. 3.3.13 B) and ER (red traces in Fig. 3.3.13 B) respectively by  two 
experimental regimes: PMA (Fig. 3.3.13 B, left) and Bryostatin 1 (Fig. 3.3.13 B, right 
panel) stimulation. Interestingly, while PMA stimulation only results in a plasma 
membrane delimited phosphorylation increase (left panel in Fig. 3.3.13 B), Bryostatin 1 
causes phosphorylation confined to the ER (right panel in Fig. 3.3.13 B). In both cases the 
phosphorylation increase cab be abrogated by the application of the pan specific PKC 
inhibitor Gö6983 [169, 170], supporting the notion that the CKAR probe preferentially 
detects PKC-dependent phosphorylation. These data show that the differential targeting of 
PKC isoforms to distinct  cellular membranes also results in opening of the molecule, 
release of the autoinhibitory  domain, and activation of the kinase domain. In chapter 3.3.1 
and 3.3.3, I have described ATP-dependent ER recruitment of PKC$ and introduced the 
signaling mechanism leading to PKC$ recruitment. Now I wanted to test whether such 
regimes indeed also cause increased phosphorylation at the ER membrane, i.e. whether 
such translocations also translate into kinase activity of the PKC$ molecule. For this 
purpose I transfected HEK293 cells with erCKAR and stimulated them with various 
agonists recruiting PKC$ to the ER membrane (see Fig. 3.3.2 & 3.3.6). Interestingly, both 
ATP and the Epac specific cAMP analogue, 8-pCPT-2’-O-Me-cAMP caused robust 
increases of phosphorylation at the ER membrane as depicted in Fig. 3.3.13 C. Because 
there is no specific inhibitor of PKC$, I thought of a different approach to support  my 
notion that the stimulation regimes illustrated in Fig. 3.3.13 C indeed resulted from PKC$ 
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Fig. 3.3.13 Directed PKC translocation is associated with kinase activity at the target membrane. (A) 
Subcellular distribution of PKC phosphorylation sensors pmCKAR (left) and erCKAR (right). Scale bars 
depict 10 µm. (B) pmCKAR and erCKAR were expressed in HEK293 cells and stimulated with PMA (left 
panel) and Bryostatin 1 (right panel). Green traces denote the apparent FFET efficiency detected by 
pmCKAR while the red one indicates signals from erCKAR. Note that FRET  deceases indicate 
phosphorylation activity increases. (C) HEK293 cells expressing erCKAR were challenged with different 
agonists recruiting PKC" to the ER membrane. (D) Over-expression of PKC"-TagRFP-T increases 
Bryostatin 1-induced increases of ER phosphorylation activity. Statistical analysis shows the apparent FRET 
changes 30 min after the onset of the Bryostatin 1 stimulation in control (white bar) and in cells expressing 
the PKC" constructs (black bar). n=26-28 in each group from 4 independent experiments.
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recruitment to the ER membrane. In theory, other nPKCs expressed in the HEK293 cells 
and could also provide the necessary  kinase activity. For this purpose I over-expressed 
fluorescent-labeled PKC$ and tested the effects of PKC$ over-expression on the ER-
confined kinase activity following stimulation with Bryostatin 1 (Fig. 3.3.13 D). 
Interestingly, ER-limited phosphorylation was almost doubled in the PKC$ over-
expressing cells strongly indicating that PKC$’s ER accumulation indeed translates into 
increases of phosphorylation around the ER membrane.
3.3.7 Recruitment of PKC" to the ER reduced InsP3-sensitivity of 
 the InsP3R
The last series of experiments addressed the question about the possible physiological 
relevance of ER-targeted PKC$ recruitment and which putative phosphorylation targets 
might be involved. Because global Ca2+ signals are regarded as a very sensitive and 
integrative function of the cell, I investigated whether PKC$ recruitment to the ER might 
modulate global Ca2+ signaling in HEK293 cells and how it may  happen. Stimulation of 
naïve HEK293 cells with 50 ,M  ATP resulted in Ca2+ oscillations (Fig. 3.3.14 A, left  panel 
green line), while stimulation Bryostatin 1 pre-incubated HEK293 cells with ATP showed 
much shorter lifetime of Ca2+ oscillations (Fig. 3.3.14 A, left panel). I quantified the 
lifetime of these global Ca2+ signals by fitting the relaxation phase of the Ca2+ transient 
with a mono-exponential decay function (dashed lines in Fig. 3.3.14 A, left panel). The 
further statistical analysis of the decay time constant of these global Ca2+ signals show that 
the Bryostatin 1 treated cells generate Ca2+ signal with a significantly faster relaxation 
period.
Several aspects of intracellular Ca2+ handling might be modulated after PKC$ activation 
that can explain the observed changes in the Ca2+ transients. (i) Ca2+-ON mechanisms, 
such as ER-Ca2+ release by the InsP3R or (ii) Ca2+-OFF mechanisms such as intracellular 
Ca2+ buffering, plasma membrane Ca2+ efflux or SERCA-mediated ER Ca2+ uptake. To test 
whether cellular Ca2+ removal mechanisms might be altered, I set up an experiment in 
which I inhibited the InsP3R by higher concentrations of caffeine [171] and suppressed 
plasma membrane Na+/Ca2+ exchanger activity  by substituting extracellular Na+ with Li+ 
[172]. Thereafter I specifically  increased intracellular Ca2+ by UV flash photolysis of 
caged-Ca2+ and analyzed the resulting Ca2+ transient as depicted in Fig. 3.3.14 B, left 
panel. Before (green traces and bar) and following pre-stimulation of HEK293 cells with 
Bryostatin 1 (red traces in bar) the decay time constants of the mono-exponential Ca2+ 
decay were indistinguishable and statistically not different. Thus I concluded that putative 
alterations of Ca2+ removal processes are not affected by the pre-stimulation protocol. Thus 
I wondered whether ER-mediated Ca2+ release might be dampened following Bryostatin 1 
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pre-incubation. To test this hypothesis, I compared naive and pre-stimulated HEK293 cells 
while inducing ER-Ca2+ release by a robust UV flash after loading the cells with a 
membrane permeable caged InsP3 (Fig. 3.3.14 C). Interestingly, the peak Ca2+ 
concentrations reached during flash photolysis were the same in both populations, but 
when I analyzed the decay  time constant of the global Ca2+ transient I found that after pre-
stimulation of the cells with Bryostatin 1, relaxation was significantly faster. How can this 
be envisaged?
An earlier report described consensus sequences in the InsP3R for putative PKC 
phosphorylation and the authors speculated that  such phosphorylation might modulate the 
InsP3R’s sensitivity towards its natural agonist InsP3 [173, 174]. Would indeed be a 
decreased sensitivity sufficient to explain my results? Following UV flash photolysis of 
caged-InsP3 the InsP3 concentration most likely rapidly decreased due to the intrinsically 
high metabolization rate for InsP3. Thus the observed faster decay  in InsP3-induced global 
Ca2+ transients could indeed be explained by a decreased sensitivity of the InsP3R.
To test effects of PKC phosphorylation on InsP3R in living cells, I set up a graded InsP3 
photolysis assay in living HEK293 cells with the modified Tyrode solution, which intended 
to avoid the interference from the Na+/Ca2+ exchanger in the plasma membrane. By 
adjusting the flash energy, I established that  1/4 of the full UV-flash energy was just above 
the threshold for inducing global Ca2+ transients while the full energy generated a super-
maximal InsP3 increase and thus inducing a robust Ca2+ response. While two successive 
flashes with 25% and 100% energy  triggered two robust responses in control conditions 
(Fig. 3.3.15 A, green trace), pre-stimulation with Bryostatin 1 reduced the first Ca2+ 
response by more than 70% (Fig. 3.3.15 A, red trace). The reduction was reversed by 
simultaneous pre-incubation with Bryostatin 1 and the PKC inhibitor Gö6983 (Fig. 3.3.15 
A, blue trace). The amplitude of the first peak and the ratio of two responses, which may 
correct for the Fluo-4 loading difference between cells, were quantitatively  analyzed and 
the statistical results presented in Fig. 3.3.15 B. All of these data demonstrate that 
Bryostatin 1 dramatically affects the sensitivity of InsP3R towards InsP3.
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Fig. 3.3.14 Bryostatin 1 alters Ca2+ mobilization. (A) Fura2-loaded HEK293 cells were challenged with 50 
µM ATP before and after Bryostatin 1 incubation (green and red colors,  respectively). The decaying Ca2+
oscillations were fitted with mono-exponential equations (black dotted lines) and the obtained # value was 
statistically analyzed (bar graphs). Two-tail t-test, p<0.001, n=101-107 in each group from 4 experiments. (B) 
Fluo-4 and NP-EGTA loaded HEK293 cells were pretreated with 10 mM caffeine and subjected to a UV 
flash to release Ca2+ in 0 mM Na+ and 10 mM EGTA modified Tyrode solution. Green and red traces indicate 
Ca2+ signal in the absence of and following Bryostatin 1 incubation, respectively. The decay phase of Ca2+
transient was fitted with a mono exponential decay equation and the analysis of the time constant is depicted 
in the bar graphs. Two-tail t-test, p>0.05, n=115-194 in each group from 4 experiments. (C) Fluo-4 and ci-
InsP3 loaded HEK293 cells were subjected to a UV flash to release InsP3 in 0 mM Na+ and 10 mM EGTA 
modified Tyrode solution. Green and red traces indicate Ca2+ signal in the absence of and following 
Bryostatin 1 incubation, respectively. The decay phase of Ca2+ transient was fitted with a mono exponential 
decay equation and the obtained # value was analyzed in the bar graphs. n=68-94 in each group from 4 
experiments.
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Fig. 3.3.15 Sensitivity of InsP3R towards InsP3 is decreased by Bryostatin 1 pre-stimulation. (A) The traces 
show the intracellular Ca2+ signal upon InsP3 uncaging under control condition (green),  with Bryostatin 1 
pretreatment (red), and with Bryostatin 1 and Gö6983 treatment (blue). (B) The bar graphs show the 
corresponding statistical analysis of the amplitude of the 1st Ca2+ transient (left graph) and amplitude ratio 
(right graph). n=78-156 from 4 experiments.
To verify that the Bryostatin 1-induced reduction in the sensitivity of the InsP3R towards 
InsP3 was mediated by  PKC$, I thought of using PKC$ mutation with a “dead” kinase 
domain (PKC$-DN) in a dominant negative approach. As reported previously [175, 176], 
two different mutations, PKC$-K376R-eGFP and PKC$-K347R_T507E-eGFP, were 
constructed and expressed in HEK293 cells. Both of them mutated the 347th residue from 
Lys to Arg at the kinase domain, but the latter also alters the 507th residue from Thr to Glu. 
Interestingly, PKC$-K376R aggregated in the Golgi apparatus when expressed in HEK293 
cells and the cells did not respond to Bryostatin 1 (Fig. 3.3.16. Aa), while PKC$-
K376R_T507E expressing HEK293 cells resembled the behavior of wt-PKC$ expressing 
cells (Fig. 3.3.16 Ab). Thus, I used PKC$-K347R_T507E as the dominant negative mutant 
for further studies.
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Fig. 3.3.16 PKC" activation desensitizes the InsP3R towards InsP3. (A) The distribution of PKC"-K347R and 
PKC"-K347R_T507E upon Bryostatin 1 stimulation at the pointed time. The scale bars depict 10 µm. (B) 
The traces shows Ca2+ signals obtained from wild-type (upper) and PKC"-DN over-expressing (lower) 
HEK293 cells following InsP3 uncaging with (red) or without (green) Bryostatin 1 pretreatment. The bar 
graphs depict the corresponding statistical analysis of the amplitude of the 1st Ca2+ transient (left) and 1st 
over 2nd ratio (right). n= 69-106 from 4 experiments.
When comparing HEK293 cells over-expressing the dominant negative mutant of PKC$
with HEK293 cells expressing the wild-type form, I found that Bryostatin 1 induced 
changes in global Ca2+ handling were abrogated (Fig. 3.3.16). While in the presence of the 
wild-type form, Bryostatin 1 was able to significantly reduce the amplitude of the first Ca2+
transient (25% UV flash energy, see Fig. 3.3.15), this effect was basically  absent in cells 
expressing the dominant negative form of PKC$ (Fig. 3.3.16 B). This effect was also 
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obvious after analyzing the amplitude ratio of the first over the second Ca2+ transient 
(100% flash energy) as depicted in Fig. 3.3.16 B.
Taken together, these results strongly indicate that the ER-specific recruitment of PKC$ 
resulted in a reduction of the InsP3R’s sensitivity towards InsP3 and cause a dampening of 
Ca2+ oscillation following ATP stimulation. Thus, eventually, DAG production at the ER 
membrane can physiologically alter global Ca2+ signaling through PKC$-mediated 
phosphorylation of the InsP3R. Such a modulation has the potential to physiologically or 
pathophysiologically alter Ca2+-dependent gene expression [177, 178].
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Chapter 4 
DISCUSSION
4.1 PKC! translocation is diffusion-driven and independent 
 of the cytoskeleton
4.1.1 Diffusion-driven Ca2+-dependent PKC! translocation
Protein kinases C are ubiquitously  expressed and fulfill vital functions in almost  all 
eukaryotic cells. Consequently, the regulation and activation mechanisms of PKC isoforms 
deserve detailed investigations to understand their physiological and pathophysiological 
functions. It is generally accepted that translocation of PKC molecules from their “resting” 
location to their point of activation represents an essential step in their activation 
mechanism. In particular for cPKCs that respond to intracellular Ca2+ signals [21, 87], their 
mobility  and/or mode of translocation appears important to understand. Furthermore it was 
reported that  the cytoskeleton plays an important role in the activation of PKC molecules 
[104, 122-124, 149]. Here I established a quantitative method in living cells to explore the 
detailed mechanisms of Ca2+-induced PKC! translocation to the plasma membrane and its 
relationship  to cytoskeleton elements by means of a kilobeam laser scanning microscope, 
biophysical manipulation of intracellular Ca2+, and cell based-image analysis. 
Taking advantage of the high temporal and spatial resolution offered by modern 2D 
confocal microscopes, I was able to observe and analyze the entire confocal cross section 
rather than a single line. Moreover, by  using UV-flash photolysis of caged Ca2+ I gained 
independence of signaling mechanisms upstream of intracellular Ca2+ rises. Similarly to an 
earlier report  [87], I was also able to identify subplasmalemmal PKC-depletion during the 
early stage of the translocation process (see Fig. 3.1.2), which is characteristic for a 
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diffusion-driven process rather than an active transport  of molecules. Moreover, such an 
approach allowed characterization of the translocation process in a quantitative way. 
Detailed image analysis enabled me to delineate the accumulation of PKC! at the inner 
leaflet of the plasma membrane and simultaneous depletion in the neighboring cytosol. It 
should be noted here that the steepness of the upstroke of the membrane fluorescence can’t 
simply  be attributed to the kinetics of PKC!-membrane binding but also reflects the 
diffusion process of cytosolic PKC! that contributes to the accumulation. Because I was 
not able to distinguish these two processes, I regarded the 0 value obtained from the 
mathematical fitting as a characteristic value to quantify  the process of PKC! 
translocation.
4.1.2 Kinetics of oligomerized PKC! in the process of plasma 
 membrane translocation
In eukaryotic cells, simple diffusion, facilitated diffusion, and active transport are three 
main mechanisms for protein transport. Simple diffusion is the result of thermal 
fluctuations of molecules and is often referred to as Brownian motion relying on 
thermodynamics of the system. Facilitated diffusion and active transport both need specific 
carrier proteins. Similar to simple diffusion in facilitated diffusion, molecules flow from 
areas of high concentration to those of lower to reach equilibrium. In active transport, 
molecules are transported against their concentration gradients, from areas of low 
concentration to those of higher concentration. Taking these considerations into account for 
the process of PKC! translocation, particularly from the central region of the cytosol to the 
subplasmalemmal cytosol, it  is very important to understand the detailed diffusion 
mechanisms determining or contributing to this process. In the simple diffusion model and 
for a given concentration gradient, the rate of protein flux in living cells is mostly 
determined by  the hydrodynamic radius of the protein, also called Stokes radius, which 
correlates with the molecular mass of soluble globular proteins [179]. In contrast to that, 
for facilitated diffusion the rate of protein movement relies on the number of carrier 
proteins [179].
Using two forms of oligomerized fluorescent  proteins, monomer and tetramer, fused with 
PKC!, I analyzed the membrane accumulation by  its characteristic 0 value for each PKC! 
fusion construct. This was performed to address two questions: (i) is the photolysis assay 
sensitive enough to detect different diffusion rates at all and (ii) is the photolysis assay 
reliable enough to yield quantitative information about the translocation process. 
Interestingly, I obtained translocation velocity ratios for the PKC!-tetramer over the 
PKC!-monomer of around 4 (Fig. 3.1.5), which exactly  fitted the reported ratio (3.8 ± 0.4) 
for the hydrodynamic radii of DsRed (tetramer) in comparison to the monomer [148]. 
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These data not only  further reassured a diffusion-driven mechanism as the main 
mechanism for PKC! translocation, but also strongly indicated that there is no additional 
carrier protein involved in this translocation process.
4.1.3 PKC! translocation is independent of an intact cytoskeleton
In simple diffusion, beside the hydrodynamic radius, the absolute temperature and the 
viscosity  of the medium are also important determinants. In living cells at least  during the 
course of an experiment, the temperature can be seen as constant and is therefore not 
relevant. In contrast, the viscosity of the medium is an important variable [179]. In my 
case, under resting conditions PKC! proteins reside in the cytoplasm and following Ca2+ 
increases translocate to the plasma membrane. During the course of translocation, the 
cytoskeleton could modulate the apparent viscosity of the cytosol, of which it constitutes a 
major component.
Using pharmacological approaches, I successfully depolymerized cytoskeletal components, 
the actin filaments and the microtubules, and analyzed possible effects such interventions 
might have for the relative speed of PKC! translocation. Because I did not reveal 
significantly different photolytic release of Ca2+ (Fig. 3.1.7) and no obvious morphological 
change of the cells (Fig. 3.1.6 and 3.1.8 A), the results from the experiments clearly 
indicated that neither actin filaments nor microtubules were directly responsible or 
involved in Ca2+-dependent plasma membrane translocation of PKC!.
In addition to actin filaments and microtubules, the third component of the cytoskeleton, 
intermediate filaments, also needs to be considered. The molecular components of 
intermediate filaments, however, are very variable amongst different  cell types and the 
filaments are much more stable and durable in living cells. It still remains a challenge for 
those who want to manipulate them [180]. In addition, it was reported that intermediate 
filaments mostly  participate to withstand mechanical stress rather than mediating transport 
[121, 181]. The putative contribution of molecular transport along intermediate filaments 
to PKC! translocation requires further investigations. 
It’s worthwhile to note here that although my results excluded the contribution of active 
actin filament- and microtubule-mediated PKC! transport to the translocation process and 
also the role passive binding might have, the possibility  of interactions between PKC! and 
actin or tubulin can’t be exclude for the resting situation, which I mentioned in the 
introduction section. One of the possible interpretations might  be that the PKC!-Ca2+ 
binding changes the conformation of PKC! and interrupts PKC!-cytoskeleton interactions.
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4.1.4 Summary and perspective 
In this study, I applied PKC!-fluorescent protein fusion constructs combined with 
advanced optical imaging methods in living cells to demonstrate that translocation of 
PKC!, one member of the cPKC subfamily, appears purely diffusion-driven with no 
detectable contribution of filamentous transport to the membrane recruitment process, 
neither along the actin filaments nor along the microtubules. Since protein transport along 
intermediate filaments also appeared rather unlikely, PKC! recruitment to the plasma 
membrane can be regarded as a purely diffusion-driven process. 
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4.2 Self-organized clustering of membrane-bound cPKC
4.2.1 The novel theoretical model of membrane-bound cPKC 
Due to the fast association and disassociation kinetics of the cPKC-plasma membrane 
interaction, cPKC molecules work as an ideal intracellular Ca2+ signal read out mechanism, 
which is able to response to the large variety of cellular Ca2+ signals, from global Ca2+ 
waves to local Ca2+ events [21, 88, 89]. Furthermore, our group’s previous study revealed a 
more complex pattern of cPKC translocation events upon threshold stimulations of cells 
with Ca2+-mobilizing agonists. In particular, we found that a certain population of local 
translocation events (LTE) of PKC! that resulted from so-called Ca2+ puffs exceeded their 
lifetime by more than 5 fold [88], which can’t be explained by prevalent PKC knowledge 
or mechanisms of biochemistry and molecular biology. Nevertheless, as of yet unknown 
mechanisms apparently increase PKC!’s membrane residence time, a possibly important 
mechanism that might foster putative PKC!-target protein interactions such as 
phosphorylation and thus would significantly advance signaling downstream of PKC!.
In an ongoing collaboration with the group of Prof. Karsten Kruse from the department of 
Theoretical Physics at the Saarland University, it  was hypothesized that theoretically 
putative interactions between membrane-bound PKC! molecules such as they  might occur 
in PKC! clusters could prolong membrane residence times locally  and would be sufficient 
to explain the occurrence of long-lived LTEs.
Briefly, originating from the dynamic properties of PKC! and the biochemical principle of 
lipids on the plasma membrane that only  the Ca2+-bound PKC! is able to bind membrane 
but such a binding is weak if without participation of DAG, the PKC!-PKC! interaction 
might indeed play a critical role in prolonging PKC!’s membrane recruitment [182]. 
Previous reports investigating the kinetics of PKC!-PS interactions showed that the 
average membrane residence time of Ca2+-occupied PKC! molecules is only about 50 ms 
[135, 183], but the phosphorylation rate of PKC! is “slow”, less than 10 reactions per 
second [95, 125]. Thus, any  mechanism that would contribute to increased membrane 
residence of PKC! would have the ability  to foster target protein phosphorylation. In our 
working model, the simultaneously coupled PKC! molecules on the membrane forms 
clusters that extend the residence time on the inner leaflet  of the plasma membrane. 
Furthermore we propose that PKC! at the membrane can exist in two states: 1) molecules 
tightly incorporated into the cluster and strongly  bound to the membrane, and 2) loosely 
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incorporated into the cluster, weakly bound to the plasma membrane and thus presenting a 
“defect” in the cluster. Thus, if PKC! molecules are located at the boundary  of the cluster 
and are in state (2) they can detach from the membrane and destabilize the cluster. If 
located inside the cluster, molecules in state (2) cannot detach but will increase the rate at 
which neighboring molecules transit into from state (1) into state (2) and thus substantially 
destabilize the entire cluster leading to something we refer to as avalanche-like cluster 
disassemble. This process is illustrated in Fig. 4.2.1. Here the mathematical modeling 
provides an innovative aspect for our understanding of how putative protein-protein 
interactions and spontaneous cluster formation increase membrane residence times and 
thus possibly fosters downstream signaling of PKC!.
Fig. 4.2.1 Schematic representation of PKC! protein–protein interaction on the plasma membrane. The 
cytosolic PKC! can bind to Ca2+. Ca2+-PKC! can bind to PS and PIP2 in the membrane and form clusters. 
After a Ca2+ decrease, Ca2+ can detach from strongly bound PKC! due to a conformational change of the 
molecule. At the boundary of the PKC! cluster, molecules not bound to Ca2+ can detach from the membrane. 
An avalanche-like dissociation would be the result.
4.2.2 Properties of PKC!-plasma membrane interactions
To support this hypothesis, the putative protein-protein interactions between membrane-
bound cPKC molecules requires experimental verification. For this purpose I employed 
FRET measurements to quantitatively  analyze putative interactions of PKC!-CFP and 
PKC!-eYFP on the plasma membrane of living cells.
To simultaneously monitor different cellular responses such as Ca2+ mobilization, protein 
translocation, and protein-protein interactions, I employed multiplexed spectral imaging. In 
addition, to more precisely  quantify the energy  transfer from CFP to YFP fluorescent 
proteins (and thus PKC!-PKC! interactions), the apparent  FERT efficiency was measured 
and calculated, instead of simple YFP/CFP fluorescent ratios. By taking the spectral 
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properties of the two fluorophores and possible excitation and emission cross-talk into 
account, calculation of the apparent FERT efficiency help me to correct for the influence of 
incomplete labeling and unpaired donor and acceptor molecules [146].
My novel finding that there are transient increases in FRET between PKC! molecules 
following ATP stimulation of the expressing cells (Fig. 3.2.1) provided the first direct 
evidence that following physiological stimulation regimes intimate PKC!-PKC! 
interactions do indeed occur. I was even able to break down the required conditions under 
which this interaction occurs. In experiments using permeabilized HEK293 cells I was able 
to demonstrate that changes in the Ca2+ concentration were sufficient for PKC!-PKC! 
interactions to occur at the plasma membrane (Fig. 3.2.2). The fact that Ca2+ increases 
were sufficient also excluded a significant contribution of DAG to this process.
According to the principle of FRET, however, fluorescent energy transfer between two 
fluorophores depends on the distance of donor and acceptor and consequently  FRET could 
come around by molecular crowding instead of specific molecular interactions [151, 152]. 
During the translocation process, when the cytosolic PKC! proteins are recruited from 
their three dimensional movement in the cytosol into the two dimensional space of the 
plasma membrane, the packing density  of PKC! molecules substantially increases 
resulting in a robust drop  of the distance between PKC! molecules. Therefore one has to 
seriously consider whether such unspecific processes between molecules undercut the 
distance below which FRET can occur in the absence of specific intermolecular 
interactions.
4.2.3 Self-organized clustering of membrane-bound PKC!
Another major finding of this series of experiments was that in the continuous presence of 
high Ca2+ concentrations “spontaneous” FRET decay occurred (Fig. 3.2.3). In addition I 
could demonstrate that this appeared despite a continuous strong membrane recruitment of 
PKC! and in a Ca2+-dependent manner (Fig. 3.2.3 D). My interpretation of these very 
important findings was that once PKC! molecules have been recruited to the plasma 
membrane they closely  interact forming very  stable clusters of PKC!. This process 
underlies the strong increase in apparent FRET efficiency. But how can we reconcile this 
notion with the spontaneous FRET decay occurring during later periods?
There are indeed a couple of possible explanations for this phenomenon. The two most 
prominent ones are: (i) The Ca2+ ionophore used (ionomycin) is exchanging Ca2+ ions for 
protons and thus especially high Ca2+ fluxes might be associated with decreases in the pHi. 
It is well known that  the spectral properties of GFP variants are pH dependent  to a varying 
degree [184]. (ii) The decreasing FRET signal might represent changes in the way PKC! 
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molecules interact and is indeed the molecular correlate of the conformational switch 
proposed in the mathematical model for LTEs discussed above and depicted in Figure 
4.2.2.
Interestingly, the original data from the simultaneous measurements of FRET and 
intracellular Ca2+ (Fig. 3.2.3 B) addressed the first concern, changes of pHi. Here, the time 
course of the intracellular Ca2+ concentration and the apparent FRET signal displayed a 
prominent deviation. Despite a constant increase of Ca2+i following introduction of the 
high Ca2+o treatment, the FRET signal showed a complex time course, a strong upstroke in 
the early phase and a spontaneous decay at later time points. These data suggested an 
independency of the FRET decay from pHi changes. 
The other idea would indeed support the mathematical modeling suggested above in 
collaboration with the group of Prof. K. Kruse, namely cluster formation at the plasma 
membrane with strong intermolecular and plasma membrane interactions, possible switch 
of the molecule’s state into a weakly bound mode that destabilizes the cluster and decay of 
the cluster size. After increasing the Ca2+ concentration, the PKC! concentration at the 
inner leaflet of the plasma membrane increases and cluster formation between large 
numbers of PKC! molecules takes place (strong FRET increase). The spontaneous FRET 
decay that I found never resulted in a total loss of FRET (i.e. FRET returning to pre-
stimulation levels) instead it  always plateaued at a higher level, suggesting that instead of 
detachment of the PKC! molecules the intermolecular interaction might get weaker, 
probably  as a result of a steric switch in the PKC! molecule as incorporated in the 
mathematical model. Indeed, several reports seem to suggest the possibility  of a different 
mode of plasma membrane-C2 domain interaction. In addition to the well known Ca2+-C2 
domain-PS interaction, these reports brought forward the additional notion of C2-PIP2 
interactions [53, 185]. Moreover, this interaction also results in a substantially  altered 
interaction angle between the C2-domain and the leaflet  of the membrane [53, 186, 187] 
that could give rise to the steric changes in the entire PKC! molecule and might thus be 
responsible for the weaker PKC!-PKC! interactions and the lower FRET levels. However, 
this possibility would need additional experimental attention in the future.
4.2.4 Summary and perspective
By means of multi channel fluorescent recordings and parallel measurements of FRET 
efficiency in living cells, I revealed a novel Ca2+-dependent PKC!-PKC! interaction at the 
inner leaflet of the plasma membrane that also occurred transiently during physiological 
cell stimulations. In a mathematical model in collaboration with the group of Prof. K. 
Kruse, self-organization of PKC! molecules on the plasma membrane into clusters would 
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be a sufficient explanation for such intimate intermolecular interactions. Such processes 
result in an increased lifetime of the PKC! plasma membrane interaction and extended 
membrane residence times that would give rise to an increased chance for target protein 
phosphorylation by the kinase domain. Because the phosphorylation turn over of PKCs is 
reportedly rather low ( kcat/Km 50 s-1 µM-1) [95, 188], such a mechanism would 
substantially  support phosphorylation and increase downstream signaling from PKC! 
activation.
In a more speculative way, such self-organized cluster formation might also occur in many 
other protein that contain C2 domains such as cPLA [189], Nedd4 [190], CAPRI [130], 
synaptotagmin isoforms [191-193], and more [194]. They all display Ca2+-dependent 
translocation behavior and one might thus speculate that cluster formation would result in 
fostered plasma membrane residence times and fostered downstream signaling in all cases. 
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4.3 C-domain toolkit of PKC decoding spatiotemporal signal
4.3.1 PKC! and PKC" target distinctive compartments of the cell
Compared to the well-studied subfamily of cPKCs, detailed mechanisms of nPKC 
activation are still not quit clear. This is particular true for physiological stimulation 
regimes [195-197]. Using live cells confocal imaging, I revealed a novel translocation 
pattern of PKC$ from the cytosol to intracellular membranes (Fig. 3.3.2), which I 
identified as the ER membrane system (Fig. 3.3.4). Such translocation was observed 
following physiological stimulation (ATP) but also after application of the nPKC specific 
activator Bryostatin 1 (Fig. 3.3.3).
The observed ER membrane recruitment of PKC$ challenges the popular translocation 
regimes assumed for cPKCs and nPKCs. For both subfamilies the plasma membrane was 
the reported prime target  [43, 49, 108, 133]. Furthermore, due to the high binding affinity 
of PMA to the C1 domain of cPKC and nPKC isoforms (more than 1000 fold higher than 
or DAG, the natural “agonist”) [86, 96, 136], PMA, the widely used PKC activator 
recruited all members of the cPKC and nPKC subfamilies to the plasma membrane where 
PMA enriches first (Fig. 3.3.1). Such an isoform equalization would deprive PKC! and 
PKC$ from their physiological discrimination of intracellular target membranes and target 
proteins. Moreover, taking into account that  the PKC’s kinase domain is reportedly target 
unspecific [16, 22, 24], the use of phorbol esters not only results in a mis-location of PKC 
isoforms, but also induces mis-transduction of signal cascades by unspecific 
phosphorylation through various PKC isoforms [198-204]. Such mis-conduction of 
downstream signaling may eventually even result in mis-interpretation of experimental 
data. In addition, compared to the rapid dynamics of PKC! translocation induced by Ca2+, 
the intracellular membrane targeting of PKC$ showed a slow and prolonged behavior, 
which indicated substantially different mechanism behind, while translocation with PMA 
evoked recruitment were characterized by kinetics with very similar properties. 
4.3.2 Following ATP stimulation PKC" targets the ER-membrane
Employing co-expression of targeted fluorescent proteins, I was able to precisely analyze 
the process of PKC$ translocation in living cells. Quantitative co-localization analysis of 
this subcellular targeting revealed that the ER membrane was the main target  for PKC$ 
recruitment (Fig. 3.3.4). During the analysis, I also obtained positive signals from the 
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Golgi, which can be explained as follows; (i) spatially: parts of the Golgi and the ER share 
similar locations in HEK293 cells, especially in the perinuclear region. Sometimes they are 
arranged in such a close proximity  that optical distinction between these two organelles 
becomes difficult  when using light microscopy; (ii) functionally: Golgi and ER are known 
to exchange membranes frequently  through vesicular mechanisms, thus signaling that 
converts onto the ER membrane might also, at  least to some degree, convert to the Golgi 
membranes. Nevertheless, despite some positive co-localization signals the relationship 
between PKC$ distribution and Golgi localization did not change dynamically suggesting 
that whatever signaling process causes ER-membrane recruitment of PKC$ was not 
present on the Golgi membrane. These data indicated that  the Golgi membranes were at 
least not dynamically involved in the PKC$ recruitment.
4.3.3 ER-specific DAG production recruits PKC"
Because DAG is the main physiological activator for nPKCs [20, 41, 43] and the existence 
of DAG at intracellular membranes was demonstrated directly [205, 206], I investigated 
the relationship  between ER-specific production of DAG and PKC$ translocation. Using a 
combination of pharmacological and molecular biological tools, I was able to identify a 
novel signal cascade that was responsible for ATP-induced ER targeting (Fig. 4.3.1).
Fig. 4.3.1 Proposed scheme of signaling cascades for cPKC and nPKC activation in HEK293 cells. The 
upper grey region summarizes the processes on the plasma membrane, and the lower region represents those 
on the ER membrane.
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One member of purinergic G protein-coupled receptors, the P2Y11 receptor can activate G!s 
and G!q subunits simultaneously [207] and thereby offers two possible routes for DAG 
production. The well-known G!q singling cascade originates from ligand binding over G!q 
activation to lipid hydrolysis by  PLC" in the plasma membrane. The activated PLC" 
hydrolysis PIP2 into DAG and InsP3. The latter one stimulates the InsP3R in the ER 
membrane and releases Ca2+ stored in the ER, which consequently causes cPKCs to 
translocate to the plasma membrane via Ca2+-C2 domain-plasma membrane binding. While 
Ca2+ is primarily responsible for translocation, DAG available at the plasma membrane 
causes cPKCs to achieve the competent activity following C1-DAG binding [15, 20, 33]. 
Furthermore, P2Y11 receptors can also activate G!s subunits leading to the production of 
cAMP by  stimulation of the adenylate cyclase (AC). After binding to cAMP, Epac 
subsequently  activates Rap proteins by exchanging Rap-bound GDP for GTP. Interestingly, 
RapGAP suppressed the activated Rap proteins by exchanging GTP to GDP. Thus, the 
activity of Rap proteins is controlled by the balance between Epac and RapGAP proteins 
[155, 164]. Activated Rap  proteins in turn accelerate the production of DAG in the ER 
membrane by stimulation PLC% [208, 209]. In the end it is DAG that recruits PKC$ to the 
ER membrane.
Such a signaling pathway would significantly increase the versatility of cAMP signaling by 
extending the downstream events from cAMP-dependent activation of protein kinase A 
(PKA) also to the activation nPKCs and therefore highlight the possibility of a tight 
regulatory interconnection of these two AGC protein kinase families.
In addition, the existing basal levels of cAMP in the cytosol might lead to a constitutive 
activation of the aforementioned signaling cascade resulting in a tonic, background 
production of DAG at the ER membrane. This residual DAG might be the reason for the 
partial co-localization of PKC$ and ER membrane under resting conditions (see Fig. 
3.3.4). Although the activation of PLC% was essential for the ER recruitment of PKC$, 
other phospholipase proteins, such as PLD, still may  involve in the production of DAG 
[205, 210].
4.3.4 The C-domain composition of PKCs determines their 
 translocation pattern 
Presently  there are two main hypothesis that try to explain the targeting of PKC isoforms, 
(i) binding to RACK proteins [103, 104, 108] and (ii) targeting to membrane lipids [22, 43, 
91, 92]. In order to identify which one plays the key  role, I constructed chimeras between 
PKC! and PKC$ by specific C-domain swapping. I found that regardless of the particular 
backbone, the Ca2+-sensitive C2 domain was always responsible for plasma membrane 
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targeting, while the C1 domain of PKC$ was both sufficient and necessary  for recognizing 
DAG produced at  the ER membrane. More specifically, using a similar approach than 
above, I swapped C1A and C1B domains and found that independently of the particular 
backbone the C1B domain of PKC$ was necessary and sufficient to cause ER targeted 
translocation. This notion was majorly supported by my finding that  the translocation was 
dependent on a single amino acid known to be involved in DAG binding [40, 41]. 
Moreover, both Chimera II and Chimera III displayed two fold translocation with 
targeting, the plasma and ER membrane after ATP stimuli. This was a particular important 
finding, because ATP stimulation reportedly increased DAG on both membrane but the 
C1B domain of PKC$ distinguished between both DAGs and specifically recognized DAG 
on the ER membrane. Up to now this appears difficult to explain, but in contrast  to the C2 
domain that is known to only probe very surface of the inner leaflet  of the plasma 
membrane, C1 domains are believed to be able to probe the lipid tails of DAGs by 
incorporating deeper into the lipid layer of the inner leaflet. It is important to note that 
beside the membrane-specific DAGs (such as DAGER), the particular DAG lipid 
environment of the target membranes (e.g., their polarity) can also contribute to the ability 
of C1 domains to discriminate different target membranes [36, 136]. 
The alternative targeting mechanism for PKCs involves protein-protein interactions on the 
target membrane with the “RACK” proteins. This notion claims that each PKC isoform has 
a unique interaction with different substrate proteins at distinct  subcellular sites by  specific 
RACK proteins [103]. According to this “RACK theory”, however, it  is difficult  to explain 
why Chimeras II and III can quickly shuttle between two location sites (plasma and ER 
membrane) while Chimera I and IV can’t be recruit to any of these sites. Moreover, similar 
phenomena were also observed for Chimera A, B, C, and D in which only the C1A/C1B 
domains were exchanged and thus their structure was even more similar but they still 
presented entirely distinct translocation patterns upon ATP simulation (Table 3.3.1). It  was 
even more difficult to reconcile that only a single amino acid mutation, PKC$W252K, 
entirely  altered translocation properties by changing protein-protein interactions as 
necessary  for the RACK hypothesis. Thus, differential localizations of PKCs are 
predominately determined by their C-domain content  rather than by  interactions with 
RACKs.
4.3.5 Activation model of PKC" translocation to the ER
Under physiological conditions, the stimulus for cPKC translocation is an intracellular 
Ca2+ increase [21, 88, 135, 211]. Although the Ca2+-C2 domain-plasma membrane 
interaction is rather weak with fast on and off rates [120], it  is an important prerequisite for 
the C1-DAG interaction at the plasma membrane, which is much stronger but  also much 
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more long lasting [135]. Therefore, C1-DAG interactions provide sufficient  energy for 
cPKC activation [38, 212], although some reports appear to indicate that Ca2+-C2 domain-
plasma membrane interactions might already provide some energy and might be able to 
activate cPKCs at least partially  [135]. Because PKCs are usually kept inactive by the 
binding of a pseudosubstrate domain to the kinase activity center, activation of PKCs can 
be regarded as a relief from self-inhibition [21]. With respect to the activation of nPKCs, I 
proposed a novel mechanism, in which production of the ER-specific DAG, DAGER, is the 
key for regulating nPKCs’ activity. The DAGER recruits the kinase, binds to the C1B 
domain of nPKCs and consequently provides energy to change the conformation of nPKC 
structure, which eventually  releases the autoinhibitory domain from the kinase core and 
stimulates the catalytic activity of nPKCs.
4.3.6 Local PKC phosphorylation at their distinct subcellular 
 compartment
To measure the PKC activation in living cells, the genetically  encoded PKC activity  probe, 
CKAR, was employed and provided a real-time method to detect the dynamic 
phosphorylation of PKC [22, 168]. In order to analyze PKC kinase activity  locally, on the 
plasma or on the ER membrane, local target sequences were introduced by  molecular 
approaches. It should be noted that the CKAR-probe signal can’t  separate phosphorylation 
originating from different PKC isoforms.
Importantly, the specific targeting of PKC! and PKC$ induced spatially  restricted 
phosphorylation events on their respective target  membranes (Fig. 3.3.13 B), although the 
substrate peptides within pmCKAR and erCKAR were the same. This important finding 
not only highlights spatial specificity but also supports the notion of spatiotemporally 
restricted PKC activity as a major determinant for substrate specificity. Furthermore the 
stimulation regimes from upstream signals of DAGER generation, such as ATP, 8-pCPT-2'-
O-Me-cAMP, resulted in specific phosphorylation of CKARs on the ER membrane (Fig. 
3.3.13 C). The specificity for PKC$ was supported in PKC$ over-expressed HEK293 cells, 
in which CKAR signals on the ER membrane were substantially increased.
4.3.7 Recruitment of PKC" reduced sensitivity of the InsP3R 
 towards InsP3
To highlight the physiological relevance of the specific targeting of PKC$, I investigated 
the consequence of PKC$ activation on the ER membrane. In principle, two major 
functions, protein modification and intracellular Ca2+ storage, are attributed to the ER. 
Here I put my emphasis on the latter one. After Bryostatin 1 treatment, a specific way to 
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activate nPKCs, I observed a substantial reduction of ATP-dependent Ca2+ oscillation, 
which strongly suggested a relationship between cPKC activity and Ca2+ signaling. 
It has been reported that PKC$ can directly phosphorylate InsP3R in vitro [173, 174] where 
it causes a decreased InsP3 sensitivity. Taking advantage of membrane permeable caged-
InsP3, I was able to directly substantiate such in vitro findings in situ by means of graded 
flash-photolytic InsP3 production. 
In order to efficiently block the activity  of PKC$ on the ER membrane, a competitive 
inhibitory strategy  was employed by over-expressing a kinase-dead PKC$ that still located 
and translocated properly. Such an approach offered significant advantages over PKC$ 
RNAi techniques, because while RNAi would diminish PKC$ levels in the cell and PKC$ 
binding sites would be left “free” and consequently occupied by other nPKCs and cause 
downstream signaling, PKC$-DN was thought to specifically  compete wt-PKC$ away 
from its natural binding partners at the ER membrane with minimized “side effects”.
By incorporating a single point mutation, K378R, the ATP binding site in the kinase 
domain was destroyed, so that this kinase cannot transfer phosphate groups from ATP to 
substrates anymore (kinase-dead PKC$). After expression of this mutant PKC$, I 
interestingly found misallocation of this protein under resting conditions and a lack of 
translocation following any stimulation regime (Fig. 3.3.16 Aa). Important steps in the 
protein maturation of almost all PKC members are so-called auto-phosphorylation events 
of the protein that  are critical for proper protein folding (Table 1.1 and [67]). Because the 
auto-phosphorylation is also required for maturation of PKC$, I assumed that  PKC$
1K378R proteins were folded incorrectly. I therefore introduced another mutant, T505E, in 
the Turn motif of the C-terminal tail of PKC$, where the Glu (in the mutated PKC$) could 
mimic the structure of the phosphorylated Thr (in the wt protein). This turned out to be a 
successful strategy, because it  not only rescued the protein structure but “killed” the kinase 
function. Using the dominant negative PKC$, I confirmed that PKC$ is essential for 
Bryostatin 1-induced desensitization of the InsP3R towards InsP3.
Recruitment of endogenous PKC$ to the ER will limit the positive feedback in InsP3-
dependent Ca2+ release from the ER by reducing the InsP3-sensitivity of the InsP3R. 
Moreover, modulation of global Ca2+ signals such as their duration or longevity of 
underlying Ca2+ oscillations has been shown to be effective in changing the transcription 
levels of Ca2+ regulated genes [177, 178].
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4.3.8 Summary and perspective
In summary, my experiments strongly suggested the existence of a C-domain toolkit for 
PKCs, in which C-domains can operate independently from one another. Consequently, the 
C-domain composition of a particular PKC determines its translocation behavior and 
ultimately  its target specificity. The data provided here and elsewhere [38, 213] indicate 
that lipids, in particular DAGs and their specific generation at the level of cellular 
membranes, are the major determinants of the translocation and distribution of PKCs. The 
interactions between such lipid-gated translocation mechanisms and putative alternative 
anchoring proteins [82, 104, 111] vastly increase the versatility of PKC signaling.
In conclusion, I demonstrate how cells utilize various toolkits, in particular the Ca2+ toolkit 
and the C-domain toolkit, to convert incoming stimuli into spatio-temporal complex 
phosphorylation patterns that are instrumental for appropriate cell signaling and responses.
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